uric acid has been researched along with Recrudescence in 263 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe the clinical effect of Rebixiao granule (RBXG) in treating repeatedly attacking acute gouty arthritis and through experimental study on blood uric acid to explore RBXG's therapeutic mechanism." | 9.11 | Effects of Rebixiao granules on blood uric acid in patients with repeatedly attacking acute gouty arthritis. ( Ji, W; Lu, Y; Tan, WF; Zhu, XX, 2005) |
| "To assess the short-term urate-lowering effect of fenofibrate in men on long-term allopurinol therapy for hyperuricaemia and gout." | 9.10 | Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout. ( Ball, SG; Feher, MD; Hepburn, AL; Hogarth, MB; Kaye, SA, 2003) |
| "The Anturane Reinfarction Trial is a randomized, double-blind, multicenter clinical trial comparing sulfinpyrazone (200 mg four times a day) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction." | 9.04 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. ( , 1978) |
| "Lowering serum uric acid (SUA) levels can essentially cure gout; however, this is not widely practiced." | 8.95 | Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review. ( Bolzani, A; Cheung, A; Choi, HK; Shiozawa, A; Szabo, SM, 2017) |
| "Previous studies have shown that serum uric acid (UA) modulates outcomes of neurological diseases, although little is known about cerebrospinal fluid (CSF) UA levels in neuromyelitis optica spectrum disorders (NMOSDs)." | 7.85 | Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders. ( Hu, X; Li, H; Li, R; Long, Y; Lu, Z; Peng, F; Qiu, W; Shu, Y; Wang, Y; Zhang, L, 2017) |
| "This is the first large study showing that serum uric acid is not associated with an increase in the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary revascularization." | 7.80 | Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. ( Barbieri, L; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Verdoia, M, 2014) |
| "Uric acid (UA), a product of purine metabolism, is known to be reduced in patients with various neurological disorders including multiple sclerosis (MS)." | 7.78 | Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO. ( H Lee, K; Kim, BJ; Lee, S; Min, JH; Vincent, A; Waters, P; Y Shin, H, 2012) |
| "There are limited data regarding the prognostic value of serum uric acid (UA) after acute myocardial infarction (AMI)." | 7.77 | Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. ( Bae, MH; Chae, SC; Cho, Y; Jun, JE; Lee, JH; Lee, SH; Park, HS; Park, SH; Yang, DH, 2011) |
| "We examined the association between serum uric acid (SUA) level and the frequency, risk, and cost of gout flares among the elderly." | 7.75 | Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? ( Cahill, KE; Krishnan, E; Mody, RR; Patel, PA; Tang, J; Wu, EQ; Yu, AP, 2009) |
| "The primary outcome was the late recurrence after treatment." | 5.72 | Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation. ( Çam, N; Çınar, T; Durmuş, G; Gökalp, M; Gürkan, K; Hayıroğlu, Mİ; Karataş, MB; Zengin, A, 2022) |
| "Fifty episodes of VTE recurrence occurred during the follow-up and Kaplan-Meier survival analysis showed that subjects in the lower tertile of SUA distribution had significantly lower risk of future VTE recurrence (P = ." | 5.62 | Serum uric acid levels and the risk of recurrent venous thromboembolism. ( Agostini, C; Caberlotto, L; Callegari, E; Cinetto, F; De Lucchi, L; Faggin, E; Martini, E; Nardin, C; Pagliara, V; Pauletto, P; Plebani, M; Raggi, D; Rattazzi, M; Sponchiado, A; Villalta, S, 2021) |
| "Gouty arthritis is characterized by inflammation induced by monosodium urate (MSU) crystal deposition, which is resulted by an increase of serum urate concentration." | 5.43 | The effect of resveratrol on the recurrent attacks of gouty arthritis. ( Chen, H; Liu, Q; Qiu, J; Wang, Y; Xue, Y; Zheng, S; Zhu, H; Zhu, X; Zou, H, 2016) |
| "Atrial fibrillation recurrence rates from the lowest to the highest SUA quartiles were 2." | 5.40 | Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation. ( Aras, D; Aytemir, K; Canpolat, U; Çay, S; Kaya, EB; Oto, A; Şahiner, L; Topaloğlu, S; Yorgun, H, 2014) |
| "The combined consumption of citrate and theobromine may be a promising strategy for the prevention of UA kidney stones." | 5.34 | Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine. ( Benejam, J; Calvó, P; Costa-Bauza, A; Grases, F; Hernandez, Y; Sanchis, P, 2020) |
| "In the double-blind, randomized, controlled trial, we aimed to evaluate the effects of compound tufuling oral liquid (CoTOL) on serum uric acid (sUA) levels and recurrence of acute gouty arthritis in intercritical and chronic gout treatment." | 5.24 | Hypouricemic and arthritis relapse-reducing effects of compound tufuling oral-liquid in intercritical and chronic gout: A double-blind, placebo-controlled, multicenter randomized trial. ( Fan, Y; Gao, X; Han, Y; Jing, X; Li, X; Li, Y; Sun, J; Tang, X; Wen, C; Wu, H; Xie, Z, 2017) |
| "To observe the clinical effect of Rebixiao granule (RBXG) in treating repeatedly attacking acute gouty arthritis and through experimental study on blood uric acid to explore RBXG's therapeutic mechanism." | 5.11 | Effects of Rebixiao granules on blood uric acid in patients with repeatedly attacking acute gouty arthritis. ( Ji, W; Lu, Y; Tan, WF; Zhu, XX, 2005) |
| "To assess the short-term urate-lowering effect of fenofibrate in men on long-term allopurinol therapy for hyperuricaemia and gout." | 5.10 | Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout. ( Ball, SG; Feher, MD; Hepburn, AL; Hogarth, MB; Kaye, SA, 2003) |
| "The Anturane Reinfarction Trial is a randomized, double-blind, multicenter clinical trial comparing sulfinpyrazone (200 mg four times a day) and placebo in the prevention of cardiac mortality among patients with a recent documented myocardial infarction." | 5.04 | Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial. ( , 1978) |
| "Gout is a systemic disease, characterized by the formation and deposition of crystals in tissues (mainly in and around the joints) of individuals with elevated serum uric acid levels." | 5.01 | Gout and arrhythmias: In search for causation beyond association. ( Angelidis, C; Deftereos, S; Giannopoulos, G, 2019) |
| "Lowering serum uric acid (SUA) levels can essentially cure gout; however, this is not widely practiced." | 4.95 | Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review. ( Bolzani, A; Cheung, A; Choi, HK; Shiozawa, A; Szabo, SM, 2017) |
| " Twenty-five out of 41 trials, involving 23 different herbal prescriptions, found statistical significance in lowering serum uric acid level, and the overall effect from Chinese herbal medicine in inflammation relief is better than conventional therapies in 19 trials with 17 different prescriptions." | 4.89 | Chinese herbal medicine for gout: a systematic review of randomized clinical trials. ( Han, M; Li, XX; Liu, JP; Wang, YY, 2013) |
| "to clarify the influence of osteoporosis and its causative factors on excretion of calcium, uric acid and recurrence of urinary stone disease." | 3.91 | [Inluence of osteoporosis and its causative factors on the prevention of recurrence of urinary stone disease]. ( Amosov, AV; Amosova, MV; Demidko, LS; Demidko, YL; Enikeev, ME; Fadeev, VV; Grigoryan, VA; Kuzmicheva, GM; Rudenko, VI, 2019) |
| "We performed a post hoc analysis of data from a previously published randomized controlled trial comparing the effect of 2 diets in 120 men with recurrent calcium oxalate stones and hypercalciuria." | 3.88 | Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis. ( Borghi, L; Di Maio, F; Ferraro, PM; Fulignati, P; Gambaro, G; Meschi, T; Rodgers, A; Ticinesi, A, 2018) |
| "Previous studies have shown that serum uric acid (UA) modulates outcomes of neurological diseases, although little is known about cerebrospinal fluid (CSF) UA levels in neuromyelitis optica spectrum disorders (NMOSDs)." | 3.85 | Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders. ( Hu, X; Li, H; Li, R; Long, Y; Lu, Z; Peng, F; Qiu, W; Shu, Y; Wang, Y; Zhang, L, 2017) |
| " Cox regression analysis showed that the baseline clinical and biochemical variables which associated with MACE were age, being illiterate, a widow or widower, and/or economically dependent, having triple vessel disease, stent implantation, anemia, and/or diabetes mellitus, waist to hip ratio (WHR), diastolic blood pressure, fasting glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), creatinine, estimated glomerular filtration rate (eGFR), red blood cell count, hemoglobin, hematocrit, and mean corpuscular-hemoglobin concentration (MCHC) in ACS patients, and age, malnourished, and/or economically dependent, taking hypoglycemic medication, having triple vessel disease, stent implantation, anemia, diabetes mellitus, and/or hypertension, WHR, fasting glucose, HDL-C, uric acid, creatinine, eGFR, high-sensitivity C-reactive protein, mean corpuscular volume, and MCHC in elective PCI patients." | 3.85 | The burden of major adverse cardiac events in patients with coronary artery disease. ( Chung, FM; Hsu, CC; Hung, WC; Lee, YJ; Lu, LF; Lu, YC; Tsai, IT; Wang, CP; Wu, CC; Yu, TH, 2017) |
| "ACP recommends that clinicians choose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine to treat patients with acute gout." | 3.85 | Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians. ( Barry, MJ; Boyd, C; Chow, RD; Denberg, TD; Forciea, MA; Harris, RP; Humphrey, LL; Kansagara, D; Qaseem, A; Vijan, S; Wilt, TJ, 2017) |
| " However, Group 1 presented greater urine calcium, oxalate and uric acid and a higher proportion of hypocitraturia, hypercalciuria and hyperoxaluria, as compared to Group 2." | 3.81 | The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis. ( Abad-Menor, F; Arrabal-Martin, M; Arrabal-Polo, MA; Cano-García, Mdel C; de Haro Muñoz, T; Girón Prieto, MS; Poyatos-Andujar, A; Quesada-Charneco, M, 2015) |
| "Familial renal hypouricemia (RHUC) is a hereditary disease characterized by hypouricemia, high renal fractional excretion of uric acid (FE-UA) and can be complicated by acute kidney failure and nephrolithiasis." | 3.80 | Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. ( Cancarini, G; Chiarelli, N; Colombi, M; Gaggiotti, M; Jeannin, G; Maiorca, P; Possenti, S; Quinzani, S; Ritelli, M; Verzeletti, F, 2014) |
| "This is the first large study showing that serum uric acid is not associated with an increase in the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary revascularization." | 3.80 | Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. ( Barbieri, L; De Luca, G; Di Giovine, G; Marino, P; Schaffer, A; Verdoia, M, 2014) |
| "Metabolic syndrome trait clustering is associated with greater severity of kidney stone disease; increased urinary calcium, uric acid, and oxalate excretion; and decreased urinary citrate excretion." | 3.79 | Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. ( Hara, I; Iguchi, M; Inagaki, T; Kohjimoto, Y; Matsumura, N; Sasaki, Y, 2013) |
| "Uric acid (UA), a product of purine metabolism, is known to be reduced in patients with various neurological disorders including multiple sclerosis (MS)." | 3.78 | Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO. ( H Lee, K; Kim, BJ; Lee, S; Min, JH; Vincent, A; Waters, P; Y Shin, H, 2012) |
| "There are limited data regarding the prognostic value of serum uric acid (UA) after acute myocardial infarction (AMI)." | 3.77 | Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction. ( Bae, MH; Chae, SC; Cho, Y; Jun, JE; Lee, JH; Lee, SH; Park, HS; Park, SH; Yang, DH, 2011) |
| "We examined the association between serum uric acid (SUA) level and the frequency, risk, and cost of gout flares among the elderly." | 3.75 | Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? ( Cahill, KE; Krishnan, E; Mody, RR; Patel, PA; Tang, J; Wu, EQ; Yu, AP, 2009) |
| "5), hypercalciuria-calcium greater than 200 mg, hyperoxaluria-oxalate greater than 45 mg, hyperuricosuria-uric acid greater than 600 mg, hypocitraturia-citrate less than 600 mg and purine gluttony-sulfate greater than 20 mg." | 3.73 | Ethnic background has minimal impact on the etiology of nephrolithiasis. ( Ekeruo, WO; Enemchukwu, CU; Maloney, ME; Preminger, GM; Springhart, WP; Young, MD, 2005) |
| "In an analysis, by both crystallographic and microbiological methods, of 50 urinary calculi recently removed by surgical operation, 33 proved to be of metabolic origin (mostly calcium oxalate and some uric acid or urate) and 17 of 'infective' origin (struvite, apatite or a mixture of the two)." | 3.67 | Bacteriological and crystallographical analysis of urinary calculi: aid to patient management. ( Brumfitt, W; Hamilton-Miller, JM; Hopewell, JP; Osborn, RS; Rosenstein, I, 1984) |
| "Baseline white blood cell count (WCC) and haematocrit were examined in relation to recurrent coronary events and to all-cause mortality in 2026 persons enrolled in the first Persantin-Aspirin Reinfarction Study (PARIS-1) 2-60 months after myocardial infarction." | 3.67 | White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. ( Barton, BA; Forbes, CD; Krol, WF; Lowe, GD; Machado, SG, 1985) |
| "KEY POINTS: • Gout flare recurrences were common within the first 3 months after starting urate-lowering therapy in gout patients." | 2.90 | Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare. ( Janssen, CA; Oude Voshaar, MAH; Ten Klooster, PM; van de Laar, MAFJ; Vonkeman, HE, 2019) |
| "The clinical efficacy, recurrence rate and adverse reactions were recorded and analyzed." | 2.80 | [Traditional Chinese Medicine Treatment of Gouty Arthritis Based on Syndrome Differentiation]. ( Chen, Q; Guo, Q; Lei, XX; Zhao, H; Zhu, RR; Zhu, YX, 2015) |
| " Gout flares and IRs were the most frequently reported adverse events; these were least common in patients with a sustained urate-lowering response to treatment and those receiving biweekly treatment." | 2.78 | Long-term safety of pegloticase in chronic gout refractory to conventional treatment. ( Baraf, HS; Becker, MA; Dillon, A; Khanna, D; Ottery, FD; Sundy, JS; Vázquez-Mellado, J; Yood, RA, 2013) |
| "Relapse of gout is common although delayed after discontinuation of ULT." | 2.58 | Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review. ( Beslon, V; Fournier, JP; Giraudeau, B; Maisonneuve, H; Maruani, A; Moreau, P, 2018) |
| "After recovery from acute renal failure (ARF), hypouricemia (0." | 2.41 | Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature. ( Awaya, Y; Kato, J; Kihara, H; Kinoshita, Y; Ogawa, T; Ohta, T; Sakano, T, 2002) |
| "The primary outcome was the late recurrence after treatment." | 1.72 | Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation. ( Çam, N; Çınar, T; Durmuş, G; Gökalp, M; Gürkan, K; Hayıroğlu, Mİ; Karataş, MB; Zengin, A, 2022) |
| "Fifty episodes of VTE recurrence occurred during the follow-up and Kaplan-Meier survival analysis showed that subjects in the lower tertile of SUA distribution had significantly lower risk of future VTE recurrence (P = ." | 1.62 | Serum uric acid levels and the risk of recurrent venous thromboembolism. ( Agostini, C; Caberlotto, L; Callegari, E; Cinetto, F; De Lucchi, L; Faggin, E; Martini, E; Nardin, C; Pagliara, V; Pauletto, P; Plebani, M; Raggi, D; Rattazzi, M; Sponchiado, A; Villalta, S, 2021) |
| "Median time to recurrence was 64 months." | 1.56 | Predictive Factors for Kidney Stone Recurrence in Type 2 Diabetes Mellitus. ( Monga, M; Prasanchaimontri, P, 2020) |
| "Primary outcomes were CT stone recurrence rate and need for surgical stone intervention." | 1.51 | Long-term Recurrence Rates in Uric Acid Stone Formers With or Without Medical Management. ( Bird, VG; Bozorgmehri, S; Canales, BK; Otto, BJ; Sharma, N; Yuzhakov, SV, 2019) |
| "Nephrolithiasis is one of the most common urinary tract diseases." | 1.48 | Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran. ( Ghorbani, F; Hadian, B; Zafar-Mohtashami, A, 2018) |
| "It is a fact that recurrence of urinary stones is a common medical problem." | 1.46 | Easy-to-use equations for the estimation of urine relative saturation in the assessment of risk of recurrence in urinary stones formers. ( Ouimet, D; Plante, G; Robitaille, R, 2017) |
| "The incidence of pediatric nephrolithiasis is increasing and therefore the etiologies contributing to today's pediatric stone formation may also be changing." | 1.46 | The Modern Metabolic Stone Evaluation in Children. ( Bevill, M; Cooper, CS; Kattula, A; Storm, DW, 2017) |
| "Urinary stones were collected mostly in the nephrology service and urology service at the Hassan II Hospital in Fez." | 1.43 | [Epidemiological study on urinary stones in the region of Fez and the risk of recurrence]. ( Arrayhani, M; Chaqroune, A; Chouhani, BA; Dami, F; El Ammari, J; El Habbani, R; Lahrichi, A; Sqalli Houssaini, T, 2016) |
| "Gouty arthritis is characterized by inflammation induced by monosodium urate (MSU) crystal deposition, which is resulted by an increase of serum urate concentration." | 1.43 | The effect of resveratrol on the recurrent attacks of gouty arthritis. ( Chen, H; Liu, Q; Qiu, J; Wang, Y; Xue, Y; Zheng, S; Zhu, H; Zhu, X; Zou, H, 2016) |
| "Symptomatic recurrence at 10 years was approximately 50% for brushite, struvite, and uric acid but approximately 30% for calcium oxalate and hydroxyapatite stones (P<." | 1.42 | Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community. ( Bergstralh, EJ; Enders, FT; Knoedler, JJ; Krambeck, AE; Lieske, JC; Rule, AD; Singh, P; Vaughan, LE, 2015) |
| "Hypercalciuria, hypocitraturia, hyperoxaluria, hyperuricosuria, and cystinuria were detected in 41%, 39%, 22%, 9%, and 4% of the patients, respectively." | 1.42 | Metabolic disorders in Turkish children with urolithiasis. ( Aydogan, G; Celiksoy, MH; Kiyak, A; Sander, S; Topal, E; Yilmaz, A, 2015) |
| "Atrial fibrillation recurrence rates from the lowest to the highest SUA quartiles were 2." | 1.40 | Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation. ( Aras, D; Aytemir, K; Canpolat, U; Çay, S; Kaya, EB; Oto, A; Şahiner, L; Topaloğlu, S; Yorgun, H, 2014) |
| "Hyperoxaluria, hypernatruria, and hypercalciuria were found in 84 (77%), 43 (39." | 1.39 | Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones. ( Aksakal, N; Bozkırlı, I; Gülbahar, O; Irkilata, L; Karaoğlan, U; Kıraç, M; Küpeli, B, 2013) |
| "Nephrolithiasis was confirmed radiographically in 39/56 patients (69." | 1.38 | Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. ( Gettman, MT; Krambeck, AE; McPhail, EF; Patterson, DE; Rangel, LJ, 2012) |
| "Crystallographic analysis of complex urinary stones with the aid of x-ray diffraction, in combination with a Rietveld structure refinement, is the method of first choice for qualitative and quantitative phase analysis." | 1.35 | [Qualitative and quantitative analysis of urolithiasis with the Rietveld method (x-ray diffraction)]. ( Bastian, HP; Bastian, PJ; Euler, H; Lümmen, G, 2008) |
| "To identify recurrence of uroliths in cats for which uroliths were submitted for analysis at the Minnesota Urolith Center in 1998, the facility's database was searched for urolith resubmissions from the same cats between 1998 and 2003." | 1.35 | Rate and frequency of recurrence of uroliths after an initial ammonium urate, calcium oxalate, or struvite urolith in cats. ( Albasan, H; Koehler, LA; Lekcharoensuk, C; Lulich, JP; Osborne, CA; Swanson, LL; Ulrich, LK, 2009) |
| "Uric acid urolithiasis was predominant in men in this study." | 1.35 | Local factors compared with systemic factors in the formation of bladder uric acid stones. ( Chou, YH; Huang, CH; Huang, SP; Li, CC; Li, WM; Liu, CC; Wu, WJ, 2009) |
| "Twelve of the diverticulum patients (five men and seven women) had complete 24-h urine collections, all of whom had at least one metabolic abnormality." | 1.33 | Metabolic abnormalities associated with calyceal diverticular stones. ( Auge, BK; Maloney, ME; Mathias, BJ; Pietrow, PK; Preminger, GM, 2006) |
| "Some studies have suggested that HUs of urinary calculi on noncontrast computed tomography may predict the stone-free rate after ESWL." | 1.33 | Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units. ( Armenakas, NA; Bruno, JJ; Fracchia, JA; Panagopoulos, G; Pareek, G, 2005) |
| "Hyperuricosuria, hyperoxaluria and a low urinary volume did not influence the risk for active stone formation." | 1.33 | Risk factors determining active urinary stone formation in patients with urolithiasis. ( Netelenbos, JC; ter Wee, PM; Zwijnenburg, PJ, 2005) |
| "However, the probability of stone recurrence estimated by Kaplan-Meier curves was as equivalent in the elderly patient group as in the younger group." | 1.32 | Urolithiasis in geriatric patients. ( Matsushita, K; Matsuzaki, S; Shima, M; Usui, Y, 2003) |
| "We describe an unusual case of MCTD (SLE-PSS) in a 37-year-old woman who developed acute gouty arthritis." | 1.31 | Gouty arthritis in a female patient with mixed connective tissue disease. ( Huang, CM, 2000) |
| "The lack of hematuria is not predictive of absence of urolithiasis." | 1.31 | Hyperuricosuria in children: clinical presentation and natural history. ( Di Toro, R; Iovene, A; La Manna, A; Marte, A; Polito, C, 2001) |
| "Calcium-oxalate stones had a lower recurrence in C (19." | 1.30 | [Clinical and metabolic features of renal calculi in adults in regard to age of onset]. ( Bagnis, C; Bruno, M; Manganaro, M; Marangella, M; Ramello, A; Tricerri, A; Vitale, C, 1999) |
| "Only 27% remained recurrence free, and 62% thereof also had pathologic urinary findings." | 1.29 | Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. ( Höbarth, K; Hofbauer, J; Szabo, N, 1994) |
| "Nine patients (43%) had a recurrence of tophi after an average period of 39." | 1.29 | Withdrawal of longterm antihyperuricemic therapy in tophaceous gout. ( Breedveld, FC; van Lieshout-Zuidema, MF, 1993) |
| "The relationship between acute lymphoblastic leukemia (ALL-L3) and stage IV small noncleaved cell lymphoma with bone marrow involvement (SNCL) was analyzed by retrospective study of 45 patients." | 1.29 | L3 acute lymphoblastic leukemia. Comparison with small noncleaved cell lymphoma involving the bone marrow. ( Arthur, DC; Brunning, R; Dayton, VD; Gajl-Peczalska, KJ, 1994) |
| "Five (7." | 1.28 | Management of uric acid stone. ( Ahmed, M; Chugtai, MN; Kaleem, M; Khan, FA, 1992) |
| "In the patients with recurrent calcium nephrolithiasis and hypercalcinosis one should look for active impairment of uric acid metabolism which should be kept in mind when an antirecurrence treatment is planned." | 1.28 | [The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria]. ( Ivanov, I; Tsachev, K, 1990) |
| "Recurrence was seen in 16." | 1.28 | [Clinical study on recurrence of urinary tract lithiasis of ESWL]. ( Kato, S; Mori, K; Nakajima, H; Ohnishi, S; Tanda, H; Ujiie, T, 1990) |
| "The indirect methods of treatment for SIADH (fluid restriction, demeclocycline, lithium, urea) are frequently of transient value while awaiting a response to chemotherapy or in patients with resistant tumors." | 1.27 | Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. ( Greco, FA; Hainsworth, JD; Workman, R, 1983) |
| "A series of 178 urinary stones is analysed qualitatively during a three year period from 1980 to 1982." | 1.27 | Stone composition and metabolic study in urinary calculous disease. ( Foo, KT; Foong, WC; Low, CO; Tan, EC; Tung, KH, 1984) |
| " In these patients it is of importance to modify the drug dosage or to abandon the prophylaxis when it interferes with the metabolic changes of renal function impairment." | 1.27 | [Prevention of calculus recurrence in impaired kidney function]. ( Hautmann, R, 1984) |
| "Therefore, in stone recurrence prevention, the administration of Milurit 300 is recommended." | 1.27 | Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300. ( Balogh, A; Brundig, P; Fünfstück, R; Schneider, HJ; Stein, G; Traeger, A, 1983) |
| "Among 50 patients with recurrent nephrolithiasis 42 formed renal stones containing calcium and 9 of these 42 patients demonstrated concomitant asymptomatic hyperuricosuria while on a self-selected diet." | 1.27 | Renal handling of uric acid in patients with recurrent calcium nephrolithiasis and hyperuricosuria. ( Gaspar, G; Gómez Mantilla, JM; Herrero, E; Martínez, ME; Mateos Antón, F; Muñoz Sanz, A; Puig, JG; Ramos, T, 1984) |
| "In recurrent stone formers, the rate of recurrence thereafter was greater than that of primary stone formers." | 1.27 | [Recurrence of upper urinary tract calculi]. ( Hikage, T; Kawamura, K; Masukagami, T; Matsuzaki, A; Mitsuhashi, S, 1988) |
| "As for stone recurrence rate, no difference was noted between group I and group II, III or IV." | 1.27 | [Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis]. ( Murayama, T; Taguchi, H, 1987) |
| "The frequency of recurrence was very high in the patients in their forties." | 1.27 | [Clinical observation of urolithiasis in Mie University Hospital]. ( Araki, T; Arima, K; Hoshina, A; Kinoshita, N; Nishii, M; Sakurai, M; Suzuki, S; Tukamoto, K; Yamakawa, K; Yanagawa, M, 1986) |
| "Allopurinol treatment in calcium stone disease appears less effective than treatment with thiazides, magnesium hydroxide or orthophosphate." | 1.27 | Allopurinol treatment of renal calcium stone disease. ( Backman, U; Danielson, BG; Fellström, B; Holmgren, K; Johansson, G; Lindsjö, M; Ljunghall, S; Wikström, B, 1985) |
| "Uric acid stones were frequently, but not invariably, associated with hyperuricosuria and acid urine, and even large uric acid calculi dissolved with a combined therapy of high fluid intake, allopurinol and an alkalinizing agent." | 1.27 | Investigation and treatment of renal calculi. ( Agostino, M; Evans, RA; Hills, E; Maher, PO; Marel, GM; Wong, SY, 1985) |
| " From the results obtained in this study, magnesium oxide in this dosage cannot be recommended for use in treatment of patients with urolithiasis." | 1.26 | Urine composition in patients with urolithiasis during treatment with magnesium oxide. ( Ahlstrand, C; Larsson, L; Tiselius, HG, 1980) |
| "Stone recurrence rates usually remain stable, or rise with successive stones; in a minority of patients, the reverse is true." | 1.26 | The natural history of calcium urolithiasis. ( Coe, FL; Keck, J; Norton, ER, 1977) |
| "A small fraction of patients with nephrolithiasis form mixed stones containing calcium and uric acid or pass both calcium and uric acid stones; 23 of 539 patients we have studied fall in this category." | 1.26 | Calcium-uric acid nephrolithiasis. ( Coe, FL, 1978) |
| "Of the 438 dogs, 111 had 155 known recurrences of calculi." | 1.26 | Recurrence of canine urolithiasis. ( Brown, NO; Greene, RW; Parks, JL, 1977) |
| "The incidence of recurrence was 23." | 1.25 | [Recurrent Urolithiasis during Childhood (author's transl)]. ( Vendl, L, 1975) |
| " The control of the hyperuricemia and gout has been satisfactorily accomplished in the Filipino patients with the long-term use of allopurinol, sometimes complemented with colchicine taken daily." | 1.25 | The Filipino and gout. ( Bayani-Sioson, PS; Torralba, TP, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 120 (45.63) | 18.7374 |
| 1990's | 37 (14.07) | 18.2507 |
| 2000's | 38 (14.45) | 29.6817 |
| 2010's | 60 (22.81) | 24.3611 |
| 2020's | 8 (3.04) | 2.80 |
| Authors | Studies |
|---|---|
| Rajendra, S | 1 |
| Karataş, MB | 1 |
| Durmuş, G | 1 |
| Zengin, A | 1 |
| Gökalp, M | 1 |
| Hayıroğlu, Mİ | 1 |
| Çınar, T | 1 |
| Gürkan, K | 1 |
| Çam, N | 1 |
| Xie, S | 1 |
| Zhang, C | 1 |
| Xie, Z | 2 |
| Zhang, J | 1 |
| Zhang, H | 1 |
| Jiang, W | 1 |
| Geraghty, RM | 1 |
| Wilson, I | 1 |
| Olinger, E | 1 |
| Cook, P | 1 |
| Troup, S | 1 |
| Kennedy, D | 1 |
| Rogers, A | 1 |
| Somani, BK | 1 |
| Dhayat, NA | 1 |
| Fuster, DG | 1 |
| Sayer, JA | 1 |
| Kawase, K | 1 |
| Takahashi, Y | 1 |
| Kotaka, H | 1 |
| Akita, K | 1 |
| Tsuchiya, K | 1 |
| Ishida, K | 1 |
| Yamada, T | 1 |
| Taniguchi, M | 1 |
| Demidko, LS | 1 |
| Rudenko, VI | 1 |
| Fadeev, VV | 1 |
| Demidko, YL | 1 |
| Amosov, AV | 1 |
| Kuzmicheva, GM | 1 |
| Grigoryan, VA | 1 |
| Enikeev, ME | 1 |
| Amosova, MV | 1 |
| Prasanchaimontri, P | 1 |
| Monga, M | 2 |
| Hernandez, Y | 1 |
| Costa-Bauza, A | 1 |
| Calvó, P | 1 |
| Benejam, J | 1 |
| Sanchis, P | 1 |
| Grases, F | 1 |
| De Lucchi, L | 1 |
| Nardin, C | 1 |
| Sponchiado, A | 1 |
| Raggi, D | 1 |
| Faggin, E | 1 |
| Martini, E | 1 |
| Pagliara, V | 1 |
| Callegari, E | 1 |
| Caberlotto, L | 1 |
| Plebani, M | 1 |
| Pauletto, P | 1 |
| Cinetto, F | 1 |
| Agostini, C | 1 |
| Villalta, S | 1 |
| Rattazzi, M | 1 |
| Huynh, LM | 1 |
| Dianatnejad, S | 1 |
| Tofani, S | 1 |
| Carrillo Ceja, R | 1 |
| Liang, K | 1 |
| Tapiero, S | 1 |
| Jiang, P | 1 |
| Youssef, RF | 1 |
| Arzoz-Fabregas, M | 1 |
| Roca-Antonio, J | 1 |
| Ibarz-Servio, L | 1 |
| Jappie-Mahomed, D | 1 |
| Rodgers, A | 2 |
| Plante, G | 1 |
| Ouimet, D | 1 |
| Robitaille, R | 1 |
| Otto, BJ | 2 |
| Bozorgmehri, S | 2 |
| Kuo, J | 1 |
| Canales, M | 1 |
| Bird, VG | 2 |
| Canales, B | 1 |
| Beslon, V | 1 |
| Moreau, P | 1 |
| Maruani, A | 1 |
| Maisonneuve, H | 1 |
| Giraudeau, B | 1 |
| Fournier, JP | 1 |
| Daudon, M | 1 |
| Jungers, P | 1 |
| Bazin, D | 1 |
| Williams, JC | 1 |
| Hadian, B | 1 |
| Zafar-Mohtashami, A | 1 |
| Ghorbani, F | 1 |
| Kulchavenya, EV | 1 |
| Kholtobin, DP | 1 |
| Brizhatyuk, EV | 1 |
| Abu-Ghanem, Y | 1 |
| Shvero, A | 1 |
| Kleinmann, N | 1 |
| Winkler, HZ | 1 |
| Zilberman, DE | 1 |
| Giannopoulos, G | 1 |
| Angelidis, C | 1 |
| Deftereos, S | 1 |
| Ferraro, PM | 1 |
| Ticinesi, A | 1 |
| Meschi, T | 1 |
| Di Maio, F | 1 |
| Fulignati, P | 1 |
| Borghi, L | 1 |
| Gambaro, G | 2 |
| Goldfarb, DS | 1 |
| Janssen, CA | 1 |
| Oude Voshaar, MAH | 1 |
| Ten Klooster, PM | 1 |
| Vonkeman, HE | 1 |
| van de Laar, MAFJ | 1 |
| Canales, BK | 1 |
| Sharma, N | 1 |
| Yuzhakov, SV | 1 |
| Saenko, VS | 1 |
| Pesegov, SV | 1 |
| Frolova, EA | 1 |
| Kohjimoto, Y | 1 |
| Sasaki, Y | 1 |
| Iguchi, M | 5 |
| Matsumura, N | 1 |
| Inagaki, T | 1 |
| Hara, I | 1 |
| Li, XX | 1 |
| Han, M | 1 |
| Wang, YY | 1 |
| Liu, JP | 1 |
| Jeannin, G | 1 |
| Chiarelli, N | 1 |
| Gaggiotti, M | 1 |
| Ritelli, M | 1 |
| Maiorca, P | 1 |
| Quinzani, S | 1 |
| Verzeletti, F | 1 |
| Possenti, S | 1 |
| Colombi, M | 1 |
| Cancarini, G | 1 |
| Verdoia, M | 1 |
| Schaffer, A | 1 |
| Barbieri, L | 1 |
| Di Giovine, G | 1 |
| Marino, P | 1 |
| De Luca, G | 1 |
| Damasio, PC | 1 |
| Amaro, CR | 1 |
| Padovani, CR | 1 |
| Leitão, VA | 1 |
| Yamamoto, H | 1 |
| Amaro, JL | 1 |
| Canpolat, U | 1 |
| Aytemir, K | 1 |
| Yorgun, H | 1 |
| Şahiner, L | 1 |
| Kaya, EB | 1 |
| Çay, S | 1 |
| Topaloğlu, S | 1 |
| Aras, D | 1 |
| Oto, A | 1 |
| Chen, H | 1 |
| Zheng, S | 1 |
| Wang, Y | 2 |
| Zhu, H | 1 |
| Liu, Q | 1 |
| Xue, Y | 1 |
| Qiu, J | 2 |
| Zou, H | 1 |
| Zhu, X | 1 |
| Holland, R | 1 |
| McGill, NW | 1 |
| Arrabal-Martin, M | 2 |
| Poyatos-Andujar, A | 1 |
| Cano-García, Mdel C | 2 |
| Quesada-Charneco, M | 1 |
| Abad-Menor, F | 1 |
| Girón Prieto, MS | 1 |
| de Haro Muñoz, T | 1 |
| Arrabal-Polo, MA | 2 |
| Celiksoy, MH | 1 |
| Yilmaz, A | 1 |
| Aydogan, G | 1 |
| Kiyak, A | 1 |
| Topal, E | 1 |
| Sander, S | 1 |
| Singh, P | 1 |
| Enders, FT | 1 |
| Vaughan, LE | 1 |
| Bergstralh, EJ | 1 |
| Knoedler, JJ | 1 |
| Krambeck, AE | 2 |
| Lieske, JC | 1 |
| Rule, AD | 1 |
| Feng, X | 1 |
| Li, Y | 2 |
| Gao, W | 1 |
| Siener, R | 1 |
| Guo, Q | 1 |
| Zhao, H | 1 |
| Zhu, YX | 1 |
| Zhu, RR | 1 |
| Lei, XX | 1 |
| Chen, Q | 1 |
| Zhao, J | 1 |
| Liu, T | 1 |
| Korantzopoulos, P | 1 |
| Letsas, KP | 1 |
| Zhang, E | 1 |
| Yang, Y | 1 |
| Zhang, Z | 1 |
| Li, J | 1 |
| Li, G | 1 |
| El Habbani, R | 1 |
| Chaqroune, A | 1 |
| Sqalli Houssaini, T | 1 |
| Arrayhani, M | 1 |
| El Ammari, J | 1 |
| Dami, F | 1 |
| Chouhani, BA | 1 |
| Lahrichi, A | 1 |
| Shah, A | 1 |
| Keir, M | 1 |
| Ducas, R | 1 |
| Crean, AM | 1 |
| Imran, K | 1 |
| Zafar, MN | 1 |
| Ozair, U | 1 |
| Khan, S | 1 |
| Rizvi, SAH | 1 |
| Qaseem, A | 1 |
| Harris, RP | 1 |
| Forciea, MA | 1 |
| Denberg, TD | 1 |
| Barry, MJ | 1 |
| Boyd, C | 1 |
| Chow, RD | 1 |
| Humphrey, LL | 1 |
| Kansagara, D | 1 |
| Vijan, S | 1 |
| Wilt, TJ | 1 |
| Bevill, M | 1 |
| Kattula, A | 1 |
| Cooper, CS | 1 |
| Storm, DW | 1 |
| Tsai, IT | 1 |
| Wang, CP | 1 |
| Lu, YC | 1 |
| Hung, WC | 1 |
| Wu, CC | 1 |
| Lu, LF | 1 |
| Chung, FM | 1 |
| Hsu, CC | 1 |
| Lee, YJ | 2 |
| Yu, TH | 1 |
| Shu, Y | 1 |
| Li, H | 1 |
| Zhang, L | 1 |
| Long, Y | 1 |
| Li, R | 1 |
| Qiu, W | 1 |
| Lu, Z | 1 |
| Hu, X | 1 |
| Peng, F | 1 |
| Shiozawa, A | 1 |
| Szabo, SM | 1 |
| Bolzani, A | 1 |
| Cheung, A | 1 |
| Choi, HK | 1 |
| Wu, H | 1 |
| Jing, X | 1 |
| Li, X | 1 |
| Han, Y | 1 |
| Gao, X | 1 |
| Tang, X | 1 |
| Sun, J | 1 |
| Fan, Y | 1 |
| Wen, C | 1 |
| Orsoni, JG | 1 |
| Zavota, L | 1 |
| Mora, P | 1 |
| Rubino, P | 1 |
| Manzotti, F | 1 |
| Pellistri, I | 1 |
| Euler, H | 1 |
| Bastian, HP | 1 |
| Bastian, PJ | 1 |
| Lümmen, G | 1 |
| Wang, CC | 1 |
| Lien, SB | 1 |
| Huang, GS | 1 |
| Pan, RY | 1 |
| Shen, HC | 1 |
| Kuo, CL | 1 |
| Shen, PH | 1 |
| Lee, CH | 1 |
| Li, WM | 1 |
| Chou, YH | 1 |
| Li, CC | 1 |
| Liu, CC | 1 |
| Huang, SP | 1 |
| Wu, WJ | 1 |
| Huang, CH | 1 |
| Wu, EQ | 1 |
| Patel, PA | 1 |
| Mody, RR | 1 |
| Yu, AP | 1 |
| Cahill, KE | 1 |
| Tang, J | 1 |
| Krishnan, E | 1 |
| Schwille, PO | 1 |
| Schmiedl, A | 1 |
| Wipplinger, J | 1 |
| Albasan, H | 1 |
| Osborne, CA | 1 |
| Lulich, JP | 1 |
| Lekcharoensuk, C | 1 |
| Koehler, LA | 1 |
| Ulrich, LK | 1 |
| Swanson, LL | 1 |
| Semins, MJ | 1 |
| Asplin, JR | 2 |
| Steele, K | 1 |
| Assimos, DG | 1 |
| Lingeman, JE | 1 |
| Donahue, S | 1 |
| Magnuson, T | 1 |
| Schweitzer, M | 1 |
| Matlaga, BR | 1 |
| Nouri-Majalan, N | 1 |
| Baghianimoghadam, B | 1 |
| Amiri, N | 1 |
| Moghaddasi-Moosavi, S | 1 |
| Dreyling, M | 1 |
| Johri, N | 1 |
| Cooper, B | 1 |
| Robertson, W | 1 |
| Choong, S | 1 |
| Rickards, D | 1 |
| Unwin, R | 1 |
| Strohmaier, WL | 1 |
| Seilnacht, J | 1 |
| Schubert, G | 1 |
| Demirkan, B | 1 |
| Güray, Y | 1 |
| Güray, Ü | 1 |
| Turak, O | 1 |
| Hajro, E | 1 |
| Korkmaz, S | 1 |
| Ortiz-Alvarado, O | 1 |
| Miyaoka, R | 1 |
| Kriedberg, C | 1 |
| Moeding, A | 1 |
| Stessman, M | 1 |
| Anderson, JK | 1 |
| Ichikawa, M | 1 |
| Kobayashi, R | 1 |
| Nakajima, M | 1 |
| Inamoto, J | 1 |
| Suzuki, D | 1 |
| Cho, Y | 3 |
| Kaneda, M | 1 |
| Yoshida, M | 1 |
| Ariga, T | 1 |
| Bae, MH | 1 |
| Lee, JH | 1 |
| Lee, SH | 1 |
| Park, SH | 1 |
| Yang, DH | 1 |
| Park, HS | 1 |
| Jun, JE | 1 |
| Chae, SC | 1 |
| Parvin, M | 1 |
| Shakhssalim, N | 1 |
| Basiri, A | 1 |
| Miladipour, AH | 1 |
| Golestan, B | 1 |
| Mohammadi Torbati, P | 1 |
| Azadvari, M | 1 |
| Eftekhari, S | 1 |
| McPhail, EF | 1 |
| Gettman, MT | 1 |
| Patterson, DE | 1 |
| Rangel, LJ | 1 |
| Kaya, MG | 1 |
| Uyarel, H | 1 |
| Akpek, M | 1 |
| Kalay, N | 1 |
| Ergelen, M | 1 |
| Ayhan, E | 1 |
| Isik, T | 1 |
| Cicek, G | 1 |
| Elcik, D | 1 |
| Sahin, O | 1 |
| Cosgun, SM | 1 |
| Oguzhan, A | 1 |
| Eren, M | 1 |
| Gibson, CM | 1 |
| Min, JH | 1 |
| Waters, P | 1 |
| Vincent, A | 1 |
| Lee, S | 1 |
| Y Shin, H | 1 |
| H Lee, K | 1 |
| Kim, BJ | 1 |
| Chew, R | 1 |
| Thomas, S | 1 |
| Mantha, ML | 1 |
| Killen, JP | 1 |
| Baer, RA | 1 |
| George, N | 1 |
| Vivekanandan, M | 1 |
| Karnam, AH | 1 |
| Füessl, HS | 1 |
| Eisner, BH | 1 |
| Sheth, S | 1 |
| Dretler, SP | 1 |
| Herrick, B | 1 |
| Pais, VM | 1 |
| Becker, MA | 1 |
| Baraf, HS | 1 |
| Yood, RA | 1 |
| Dillon, A | 1 |
| Vázquez-Mellado, J | 1 |
| Ottery, FD | 1 |
| Khanna, D | 1 |
| Sundy, JS | 1 |
| Kıraç, M | 1 |
| Küpeli, B | 1 |
| Irkilata, L | 1 |
| Gülbahar, O | 1 |
| Aksakal, N | 1 |
| Karaoğlan, U | 1 |
| Bozkırlı, I | 1 |
| Ohta, T | 2 |
| Sakano, T | 2 |
| Ogawa, T | 2 |
| Kato, J | 1 |
| Awaya, Y | 1 |
| Kihara, H | 1 |
| Kinoshita, Y | 1 |
| Feher, MD | 1 |
| Hepburn, AL | 1 |
| Hogarth, MB | 1 |
| Ball, SG | 1 |
| Kaye, SA | 1 |
| Tefekli, A | 1 |
| Esen, T | 1 |
| Ziylan, O | 1 |
| Erol, B | 1 |
| Armagan, A | 1 |
| Ander, H | 1 |
| Akinci, M | 1 |
| Mandel, N | 1 |
| Mandel, I | 1 |
| Fryjoff, K | 1 |
| Rejniak, T | 1 |
| Mandel, G | 1 |
| Weir, CJ | 1 |
| Muir, SW | 1 |
| Walters, MR | 1 |
| Lees, KR | 1 |
| Ombra, MN | 1 |
| Casula, S | 1 |
| Biino, G | 1 |
| Maestrale, G | 1 |
| Cardia, F | 1 |
| Melis, P | 1 |
| Pirastu, M | 1 |
| Usui, Y | 1 |
| Matsuzaki, S | 1 |
| Matsushita, K | 1 |
| Shima, M | 1 |
| Igarashi, T | 1 |
| Itami, N | 1 |
| Parmar, MS | 1 |
| Ekeruo, WO | 2 |
| Tan, YH | 1 |
| Young, MD | 2 |
| Dahm, P | 1 |
| Maloney, ME | 3 |
| Mathias, BJ | 2 |
| Albala, DM | 1 |
| Preminger, GM | 3 |
| Karincaoglu, Y | 1 |
| Batcioglu, K | 1 |
| Erdem, T | 1 |
| Esrefoglu, M | 1 |
| Genc, M | 1 |
| Kamel, KS | 1 |
| Cheema-Dhadli, S | 1 |
| Shafiee, MA | 1 |
| Davids, MR | 1 |
| Halperin, ML | 1 |
| Pareek, G | 1 |
| Armenakas, NA | 1 |
| Panagopoulos, G | 1 |
| Bruno, JJ | 1 |
| Fracchia, JA | 1 |
| Netelenbos, JC | 1 |
| Zwijnenburg, PJ | 1 |
| ter Wee, PM | 1 |
| Springhart, WP | 1 |
| Enemchukwu, CU | 1 |
| Ji, W | 1 |
| Zhu, XX | 1 |
| Tan, WF | 1 |
| Lu, Y | 1 |
| Aron, M | 1 |
| Yadav, R | 1 |
| Goel, R | 1 |
| Hemal, AK | 1 |
| Gupta, NP | 1 |
| Polito, C | 2 |
| Cioce, F | 1 |
| Signoriello, G | 1 |
| La Manna, A | 2 |
| Auge, BK | 1 |
| Pietrow, PK | 1 |
| Croft, JD | 1 |
| Sugimoto, T | 1 |
| Ide, R | 1 |
| Uzu, T | 1 |
| Kashiwagi, A | 1 |
| Karagülle, O | 1 |
| Smorag, U | 1 |
| Candir, F | 1 |
| Gundermann, G | 1 |
| Jonas, U | 1 |
| Becker, AJ | 1 |
| Gehrke, A | 1 |
| Gutenbrunner, C | 1 |
| Annemans, L | 1 |
| Spaepen, E | 1 |
| Gaskin, M | 1 |
| Bonnemaire, M | 1 |
| Malier, V | 1 |
| Gilbert, T | 1 |
| Nuki, G | 1 |
| Kang, EH | 1 |
| Lee, EY | 1 |
| Song, YW | 1 |
| Lee, EB | 1 |
| Perry, ME | 1 |
| Sturrock, RD | 1 |
| Earl, SC | 1 |
| Hull, R | 1 |
| Guerrero, AL | 1 |
| Martín-Polo, J | 1 |
| Laherrán, E | 1 |
| Gutiérrez, F | 1 |
| Iglesias, F | 1 |
| Tejero, MA | 1 |
| Rodríguez-Gallego, M | 1 |
| Alcázar, C | 1 |
| Elomaa, I | 1 |
| Ala-Opas, M | 1 |
| Porkka, L | 1 |
| Hainsworth, JD | 1 |
| Workman, R | 1 |
| Greco, FA | 1 |
| Weirich, W | 1 |
| Frohneberg, D | 1 |
| Ackermann, D | 1 |
| Alken, P | 1 |
| Laerum, E | 4 |
| Larsen, S | 1 |
| Pahira, JJ | 1 |
| Yarom, A | 1 |
| Rennebohm, RM | 1 |
| Strife, F | 1 |
| Levinson, JE | 1 |
| Norman, RW | 1 |
| Bath, SS | 1 |
| Robertson, WG | 2 |
| Peacock, M | 2 |
| Tan, EC | 1 |
| Tung, KH | 1 |
| Low, CO | 1 |
| Foong, WC | 1 |
| Foo, KT | 1 |
| Bianchi, C | 1 |
| Donadio, C | 1 |
| Tramonti, G | 1 |
| Garcea, G | 1 |
| Lorusso, P | 1 |
| Lucchetti, A | 1 |
| Giordani, R | 1 |
| Pierotti, R | 1 |
| Falcone, G | 1 |
| Hautmann, R | 1 |
| Baán, L | 1 |
| Jancsó, T | 1 |
| Ficsor, E | 1 |
| Makáry, G | 1 |
| Walter, G | 1 |
| Otnes, B | 2 |
| Hoffmann, L | 2 |
| Esther, G | 1 |
| Neumann, J | 1 |
| Serfling, D | 1 |
| Bast, R | 1 |
| Hosking, DH | 1 |
| Erickson, SB | 1 |
| Van den Berg, CJ | 1 |
| Wilson, DM | 2 |
| Smith, LH | 1 |
| Coe, FL | 8 |
| Palmer, H | 1 |
| Marshall, VR | 1 |
| Ryall, RL | 1 |
| Schneider, HJ | 1 |
| Brundig, P | 1 |
| Balogh, A | 1 |
| Traeger, A | 1 |
| Stein, G | 1 |
| Fünfstück, R | 1 |
| Mateos Antón, F | 2 |
| García Puig, J | 2 |
| Gaspar, G | 2 |
| Martínez, ME | 2 |
| Ramos, T | 2 |
| Martínez Piñeiro, JA | 1 |
| Ulmann, A | 1 |
| Puig, JG | 1 |
| Muñoz Sanz, A | 1 |
| Herrero, E | 1 |
| Gómez Mantilla, JM | 1 |
| Rosenstein, I | 1 |
| Osborn, RS | 1 |
| Hopewell, JP | 1 |
| Hamilton-Miller, JM | 1 |
| Brumfitt, W | 1 |
| Pak, CY | 4 |
| Baggio, B | 1 |
| Favaro, S | 1 |
| Borsatti, A | 1 |
| Tiselius, HG | 6 |
| Bengtsson, C | 1 |
| Lennartsson, J | 1 |
| Lindquist, O | 1 |
| Noppa, H | 1 |
| Strauss, AL | 3 |
| Deutsch, L | 1 |
| Parks, JH | 4 |
| Murakami, M | 1 |
| Yamaguchi, K | 1 |
| Mori, I | 1 |
| Naito, H | 1 |
| Miyauchi, T | 1 |
| Ito, H | 1 |
| Shimazaki, J | 1 |
| Millman, S | 1 |
| Ahlstrand, C | 2 |
| Larsson, L | 2 |
| Schröder, HE | 1 |
| Lohse, R | 1 |
| Böhm, WD | 1 |
| Müller, MM | 1 |
| Zechner, O | 3 |
| Moss, AH | 1 |
| Gabow, PA | 1 |
| Kaehny, WD | 1 |
| Goodman, SI | 1 |
| Haut, LL | 1 |
| Bach, D | 1 |
| Vahlensieck, W | 1 |
| Pflüger, H | 1 |
| Takemoto, M | 1 |
| Koide, T | 1 |
| Itatani, H | 1 |
| Yachiku, S | 2 |
| Kinoshita, K | 1 |
| Takaha, M | 1 |
| Leskovar, P | 1 |
| Blair, JM | 1 |
| Sorensen, LB | 1 |
| Arnsdorf, MF | 1 |
| Lal, R | 1 |
| von Mühlendahl, KE | 1 |
| Herkenhoff, H | 1 |
| Mauch, E | 1 |
| Mayer, G | 1 |
| Kornhuber, A | 1 |
| Krapf, H | 1 |
| Jürgens, R | 1 |
| Hufnagl, JM | 1 |
| Kornhuber, HH | 1 |
| Kupin, WL | 1 |
| Höbarth, K | 1 |
| Hofbauer, J | 2 |
| Szabo, N | 1 |
| Dayton, VD | 1 |
| Arthur, DC | 1 |
| Gajl-Peczalska, KJ | 1 |
| Brunning, R | 1 |
| Murakami, T | 1 |
| Kawakami, H | 1 |
| Fukuda, M | 1 |
| Shiigi, H | 1 |
| van Lieshout-Zuidema, MF | 1 |
| Breedveld, FC | 1 |
| Tykarski, A | 1 |
| Pupek-Musialik, D | 1 |
| Posadzy-Małaczyńska, A | 1 |
| Fred, HL | 1 |
| Jarrar, K | 1 |
| Boedeker, RH | 1 |
| Weidner, W | 1 |
| Lebedeva, MV | 1 |
| Balkarov, IM | 1 |
| Lukicheva, TI | 1 |
| Aleksandrovskaia, TN | 1 |
| Oleĭnikova, EB | 1 |
| Kozlova, VG | 1 |
| Shovskaia, TN | 1 |
| Ninomiya, M | 1 |
| Ito, Y | 1 |
| Nishi, A | 1 |
| Matsumoto, T | 1 |
| Koga, A | 1 |
| Hori, Y | 1 |
| Nishida, H | 1 |
| Nomura, G | 1 |
| Kato, H | 1 |
| Widmer, A | 1 |
| Schenkman, NS | 1 |
| Stoller, ML | 1 |
| Sugita, K | 1 |
| Hagisawa, S | 1 |
| Satoh, Y | 1 |
| Eguchi, M | 1 |
| Furukawa, T | 1 |
| Giannini, S | 1 |
| Nobile, M | 1 |
| Sartori, L | 1 |
| Dalle Carbonare, L | 1 |
| Ciuffreda, M | 1 |
| Corrò, P | 1 |
| D'Angelo, A | 1 |
| Calò, L | 1 |
| Crepaldi, G | 1 |
| Vitale, C | 1 |
| Tricerri, A | 1 |
| Manganaro, M | 1 |
| Bagnis, C | 1 |
| Bruno, M | 1 |
| Marangella, M | 1 |
| Ramello, A | 1 |
| Kocvara, R | 2 |
| Plasgura, P | 1 |
| Petrík, A | 1 |
| Louzenský, G | 2 |
| Bartonícková, K | 1 |
| Dvorácek, J | 1 |
| Huang, CM | 1 |
| Marte, A | 1 |
| Iovene, A | 1 |
| Di Toro, R | 1 |
| Wise, H | 1 |
| Gröbner, W | 1 |
| Walter-Sack, I | 1 |
| Debray, H | 1 |
| Cartier, P | 1 |
| Temstet, A | 1 |
| Cendron, J | 1 |
| Burchardt, P | 1 |
| Reinecke, F | 1 |
| Brien, G | 1 |
| Bick, C | 1 |
| Gremske, D | 1 |
| Vilpo, JA | 1 |
| Levanto, A | 1 |
| Jones, WA | 1 |
| Epstein, FH | 1 |
| Thomas, WC | 1 |
| Mir, MA | 1 |
| Bablumian, IuA | 1 |
| Pylypchuk, G | 2 |
| Ehrig, U | 2 |
| Wilson, DR | 2 |
| Frank, M | 1 |
| Many, M | 1 |
| Sperling, O | 1 |
| Backman, U | 2 |
| Danielson, BG | 3 |
| Johansson, G | 3 |
| Ljunghall, S | 3 |
| Heyburn, PJ | 1 |
| Hanes, FA | 1 |
| Rutherford, A | 1 |
| Clementson, E | 1 |
| Swaminathan, R | 1 |
| Clark, PB | 1 |
| Becher, R | 1 |
| Erdmann, T | 1 |
| Keck, J | 1 |
| Norton, ER | 1 |
| Yü, TF | 1 |
| Wesołowski, S | 1 |
| Milewski, JB | 1 |
| Cieślak, A | 1 |
| Nartel-Ulkowska, N | 1 |
| Brown, NO | 1 |
| Parks, JL | 1 |
| Greene, RW | 1 |
| Muechler, EK | 1 |
| Edinyĭ, IuG | 1 |
| Dziurak, VS | 1 |
| Sveshnikov, AB | 1 |
| Greene, T | 1 |
| Prien, EL | 1 |
| Takasaki, E | 1 |
| Torralba, TP | 1 |
| Bayani-Sioson, PS | 1 |
| Vendl, L | 2 |
| Williams, G | 1 |
| Chisholm, GD | 1 |
| Kawamura, T | 1 |
| Chugtai, MN | 1 |
| Khan, FA | 1 |
| Kaleem, M | 1 |
| Ahmed, M | 1 |
| Low, LL | 1 |
| Cervantes, AG | 1 |
| Melcher, WL | 1 |
| Cupisti, A | 1 |
| Morelli, E | 1 |
| Lupetti, S | 1 |
| Meola, M | 1 |
| Barsotti, G | 1 |
| Nunziata, V | 1 |
| Di Giovanni, G | 1 |
| Giannattasio, R | 1 |
| Lettera, AM | 1 |
| Mancini, M | 1 |
| Rodman, JS | 1 |
| Oh, MS | 1 |
| Baker, S | 1 |
| Morris, JS | 1 |
| Ebisuno, S | 1 |
| Morimoto, S | 1 |
| Yasukawa, S | 1 |
| Ohkawa, T | 1 |
| Androulakakis, PA | 1 |
| Michael, V | 1 |
| Polychronopoulou, S | 1 |
| Aghioutantis, C | 1 |
| Stuart, RA | 1 |
| Gow, PJ | 1 |
| Bellamy, N | 1 |
| Campbell, J | 1 |
| Grigor, R | 1 |
| Perrone, HC | 1 |
| Ajzen, H | 1 |
| Toporovski, J | 1 |
| Schor, N | 1 |
| LaPorte, J | 1 |
| Baum, N | 1 |
| Kohri, K | 4 |
| Kodama, M | 3 |
| Katayama, Y | 3 |
| Ishikawa, Y | 3 |
| Takada, M | 4 |
| Kataoka, K | 4 |
| Katoh, Y | 4 |
| Kurita, T | 4 |
| Ivanov, I | 1 |
| Tsachev, K | 1 |
| Kato, S | 1 |
| Ujiie, T | 1 |
| Mori, K | 1 |
| Nakajima, H | 1 |
| Ohnishi, S | 1 |
| Tanda, H | 1 |
| Umekawa, T | 2 |
| Jones, DP | 1 |
| Stapleton, FB | 1 |
| Kalwinsky, D | 1 |
| McKay, CP | 1 |
| Kellie, SJ | 1 |
| Pui, CH | 1 |
| Labeeuw, M | 1 |
| Pozet, N | 1 |
| Martin, X | 1 |
| Lareal, MC | 1 |
| Bek-Jensen, H | 1 |
| Ptácek, V | 1 |
| Tuíková, J | 1 |
| Koblízková, L | 1 |
| Nikkilä, MT | 1 |
| Perlberg, S | 1 |
| Azoury, R | 1 |
| Garti, N | 1 |
| Sarig, S | 1 |
| Wallace, SL | 1 |
| Singer, JZ | 1 |
| Murayama, T | 3 |
| Taguchi, H | 3 |
| Mitsuhashi, S | 1 |
| Hikage, T | 1 |
| Kawamura, K | 1 |
| Masukagami, T | 1 |
| Matsuzaki, A | 1 |
| Knispel, HH | 1 |
| Fitzner, R | 1 |
| Kaiser, M | 1 |
| Butz, M | 1 |
| González Sanz, A | 1 |
| Casas, E | 1 |
| Michan, A | 1 |
| Mateos, F | 1 |
| Ettinger, B | 1 |
| Tang, A | 1 |
| Citron, JT | 1 |
| Livermore, B | 1 |
| Williams, T | 1 |
| Surian, M | 1 |
| Malberti, F | 1 |
| Colussi, G | 1 |
| De Ferrari, ME | 1 |
| Rombolà, G | 1 |
| Benazzi, E | 1 |
| Minetti, L | 1 |
| Riess, C | 1 |
| Hess, B | 1 |
| Binswanger, U | 1 |
| Nishii, M | 1 |
| Tukamoto, K | 1 |
| Yamakawa, K | 1 |
| Sakurai, M | 1 |
| Suzuki, S | 1 |
| Araki, T | 1 |
| Arima, K | 1 |
| Kinoshita, N | 1 |
| Hoshina, A | 1 |
| Yanagawa, M | 1 |
| Boccia, RV | 1 |
| Longo, DL | 1 |
| Lieber, ML | 1 |
| Jaffe, ES | 1 |
| Fisher, RI | 1 |
| Peterson, R | 1 |
| Benson, EA | 1 |
| Brannen, GE | 1 |
| Bush, WH | 1 |
| Malaia, LT | 1 |
| Reus, LP | 1 |
| Bondarenko, MI | 1 |
| Fellström, B | 2 |
| Holmgren, K | 2 |
| Wikström, B | 2 |
| Lindsjö, M | 1 |
| Evans, RA | 1 |
| Maher, PO | 1 |
| Agostino, M | 1 |
| Wong, SY | 1 |
| Marel, GM | 1 |
| Hills, E | 1 |
| Ulshöfer, B | 1 |
| Kiechle, J | 1 |
| Grenabo, L | 1 |
| Hedelin, H | 1 |
| Pettersson, S | 1 |
| Lowe, GD | 1 |
| Machado, SG | 1 |
| Krol, WF | 1 |
| Barton, BA | 1 |
| Forbes, CD | 1 |
| Ball, GV | 1 |
| Freeman, D | 1 |
| Feldman, HA | 1 |
| Goldfarb, S | 1 |
| McCurdy, DK | 1 |
| Loebl, WY | 2 |
| Scott, JT | 2 |
| Ghani, MF | 1 |
| Parker, BM | 1 |
| Smith, JR | 1 |
| Gellman, AC | 1 |
| Malament, M | 1 |
| Bennett, AH | 1 |
| Colodny, AH | 1 |
| Smyth, CJ | 1 |
| Percy, JS | 1 |
| Fairley, KF | 1 |
| Whitworth, JA | 1 |
| Radford, NJ | 1 |
| Butler, HM | 1 |
| Williams, HE | 1 |
| Powis, SJ | 1 |
| Black, J | 1 |
| MacDougall, JA | 1 |
| Clews, JW | 1 |
| Thorpe, JJ | 1 |
| Daley, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| FEnofibRate as a Metabolic INtervention for Coronavirus Disease 2019[NCT04517396] | Phase 2 | 701 participants (Actual) | Interventional | 2020-08-18 | Completed | ||
| Does Potassium Citrate Supplementation Reduce Stone Recurrence in Calcium Phosphate Stone Formers With Risk Factors?[NCT01980004] | Phase 2 | 0 participants (Actual) | Interventional | 2013-11-30 | Withdrawn (stopped due to closure due to failure to recruit any patients that met study criteria) | ||
| Clinical Investigation of Aging Men With Renal Stones: The Role of Bone Demineralization (Metabolic and Hormonal Assessment)[NCT01246531] | 42 participants (Actual) | Observational | 2008-01-31 | Completed | |||
| [NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
| Effectiveness of WhatsApp Education and Support Messages for Urolithiasis Prevention[NCT05627622] | 200 participants (Anticipated) | Interventional | 2021-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Death from any cause during the observation period (NCT04517396)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Fenofibrate + Usual Care | 19 |
| Placebo + Usual Care | 22 |
The exploratory global rank score, or global severity score, is a nonparametric, hierarchically ranked outcome. The global rank score was generated by ranking all 701 participants on a scale of 1 to 701, from worst to best clinical outcomes. Participants were ranked by (1) time to death; (2) the number of days supported by invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); (3) The inspired concentration of oxygen/percent oxygen saturation (FiO2/SpO2) ratio area under the curve; (4) The number of days out of the hospital during the 30 day-period following randomization. (NCT04517396)
Timeframe: Up to 30 days
| Intervention | score on a scale (Median) |
|---|---|
| Fenofibrate + Usual Care | 5.03 |
| Placebo + Usual Care | 5.03 |
Number of days that participants were alive and out of the hospital during the 30 days following randomization (NCT04517396)
Timeframe: Up to 30 days
| Intervention | days (Median) |
|---|---|
| Fenofibrate + Usual Care | 30 |
| Placebo + Usual Care | 30 |
Number of days participants were alive, out of the intensive care unit, free of mechanical ventilation/extracorporeal membrane oxygenation, or maximal available respiratory support during the 30 days that followed randomization (NCT04517396)
Timeframe: Up to 30 days
| Intervention | days (Mean) |
|---|---|
| Fenofibrate + Usual Care | 28.8 |
| Placebo + Usual Care | 28.3 |
The primary endpoint of the trial is a global rank score that ranks patient outcomes according to 5 factors. The global rank score, or global severity score, is a nonparametric, hierarchically ranked outcome. The global rank score was generated by ranking all 701 participants on a scale of 1 to 701, from worst to best clinical outcomes. Participants were ranked by (1) time to death; (2) the number of days supported by invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); (3) The inspired concentration of oxygen/percent oxygen saturation (FiO2/SpO2) ratio area under the curve; (4) For participants enrolled as outpatients who are subsequently hospitalized, the number of days out of the hospital during the 30 day-period following randomization; (5) For participants enrolled as outpatients who don't get hospitalized during the 30-day observation period, the modified Borg dyspnea scale (NCT04517396)
Timeframe: 30 days
| Intervention | Ranked Severity Score (Median) |
|---|---|
| Fenofibrate + Usual Care | 5.32 |
| Placebo + Usual Care | 5.33 |
The secondary global rank score, or global severity score, is a nonparametric, hierarchically ranked outcome. The global rank score was generated by ranking all 701 participants on a scale of 1 to 701, from worst to best clinical outcomes. Participants were ranked by (1) time to death; (2) the number of days supported by invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); (3) The inspired concentration of oxygen/percent oxygen saturation (FiO2/SpO2) ratio area under the curve; (4) For participants enrolled as outpatients who are subsequently hospitalized, the number of days out of the hospital during the 30 day-period following randomization; (5) For participants enrolled as outpatients who don't get hospitalized during the 30-day observation period, a COVID-19 symptom scale rating fever, cough, dyspnea, muscle aches, sore throat, loss of smell or taste, headache, diarrhea, fatigue, nausea/vomiting, chest pain (each are rated from 0-10 then summed). (NCT04517396)
Timeframe: Up to 30 days
| Intervention | score on a scale (Median) |
|---|---|
| Fenofibrate + Usual Care | 5.05 |
| Placebo + Usual Care | 5.05 |
A seven-category ordinal scale consisting of the following categories: 1, not hospitalized with resumption of normal activities; 2, not hospitalized, but unable to resume normal activities; 3, hospitalized, not requiring supplemental oxygen; 4, hospitalized, requiring supplemental oxygen; 5, hospitalized, requiring nasal high-flow oxygen therapy, noninvasive mechanical ventilation, or both; 6, hospitalized, requiring extracorporeal membrane oxygenation (ECMO), invasive mechanical ventilation, or both; and 7, death. (NCT04517396)
Timeframe: At 15 days
| Intervention | score on a scale (Median) |
|---|---|
| Fenofibrate + Usual Care | 1 |
| Placebo + Usual Care | 1 |
20 reviews available for uric acid and Recrudescence
| Article | Year |
|---|---|
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Topics: Citric Acid; Female; Global Health; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Male; Met | 2020 |
Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.
Topics: Clinical Trials as Topic; Gout; Gout Suppressants; Humans; Observational Studies as Topic; Recurrenc | 2018 |
Gout and arrhythmias: In search for causation beyond association.
Topics: Ablation Techniques; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biomarkers; Gout; Gout Suppressan | 2019 |
Empiric therapy for kidney stones.
Topics: Calcium; Diet, Sodium-Restricted; Dietary Approaches To Stop Hypertension; Fluid Therapy; Genetic Te | 2019 |
Chinese herbal medicine for gout: a systematic review of randomized clinical trials.
Topics: Drugs, Chinese Herbal; Gout; Humans; Inflammation; Medicine, Chinese Traditional; Pain Management; P | 2013 |
Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?
Topics: Beverages; Bicarbonates; Calcium Oxalate; Citric Acid; Cystine; Humans; Hydrogen-Ion Concentration; | 2016 |
Association between serum uric acid and atrial fibrillation recurrence following catheter ablation: A meta-analysis.
Topics: Atrial Fibrillation; Biomarkers; Catheter Ablation; Cohort Studies; Humans; Postoperative Complicati | 2016 |
Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review.
Topics: Gout; Humans; Incidence; Recurrence; Risk; Uric Acid | 2017 |
An update and practical guide to renal stone management.
Topics: Age of Onset; Calcium Oxalate; Calcium Phosphates; Cross-Sectional Studies; Cystine; Diabetes Mellit | 2010 |
Exercise-induced acute renal failure with renal hypouricemia: a case report and a review of the literature.
Topics: Acute Kidney Injury; Adolescent; Creatinine; Exercise; Humans; Male; Recurrence; Uric Acid | 2002 |
Kidney stones.
Topics: Calcium; Citric Acid; Colic; Glycoproteins; Humans; Hyperoxaluria; Kidney Calculi; Magnesium Compoun | 2004 |
Recurrent uric acid stones.
Topics: Ammonia; Circadian Rhythm; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Kidney Medulla; Recur | 2005 |
Gout is a risk factor for cardiovascular disease.
Topics: Acute Disease; Algorithms; Cardiovascular Diseases; Gout; Harm Reduction; Humans; Recurrence; Risk A | 2007 |
Nephrolithiasis: current concepts in medical management.
Topics: Acidosis, Renal Tubular; Bacterial Infections; Calcium; Crystallography; Cystinuria; Diuresis; Fluid | 1984 |
Long-term course of neonatal diabetes.
Topics: Diabetes Mellitus; Female; Follow-Up Studies; Germany; Humans; Incidence; Infant; Infant, Newborn; M | 1995 |
Investigation of single and recurrent stone formers.
Topics: Calcium; Cystine; Humans; Kidney Calculi; Medical History Taking; Recurrence; Uric Acid | 1994 |
[Principles of directed prevention of urinary calculi].
Topics: Calcium; Cellulose; Drinking; Humans; Hydrogen-Ion Concentration; Magnesium; Organophosphorus Compou | 1976 |
Calcium oxalate renal stones.
Topics: Allopurinol; Calcium; Calcium Metabolism Disorders; Calcium Phosphates; Calcium, Dietary; Crystalliz | 1975 |
Kidney stones. How to identify the cause and prevent recurrence.
Topics: Calcium; Citrates; Humans; Hyperoxaluria; Kidney Calculi; Recurrence; Uric Acid | 1990 |
Therapy in gout.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calculi; Colchicine; Gout; Humans; Recurrence; Uric Acid | 1988 |
20 trials available for uric acid and Recrudescence
| Article | Year |
|---|---|
Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine.
Topics: Aged; Citric Acid; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Combinations; | 2020 |
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
Topics: Adult; Aged; C-Reactive Protein; Double-Blind Method; Female; Follow-Up Studies; Gout; Gout Suppress | 2019 |
Comprehensive dietary education in treated gout patients does not further improve serum urate.
Topics: Adult; Aged; Allopurinol; Australia; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Pat | 2015 |
[Traditional Chinese Medicine Treatment of Gouty Arthritis Based on Syndrome Differentiation].
Topics: Arthritis, Gouty; Blood Urea Nitrogen; Cholesterol; Creatinine; Drug Therapy, Combination; Drugs, Ch | 2015 |
Hypouricemic and arthritis relapse-reducing effects of compound tufuling oral-liquid in intercritical and chronic gout: A double-blind, placebo-controlled, multicenter randomized trial.
Topics: Adult; Aged; Arthritis, Gouty; Double-Blind Method; Drugs, Chinese Herbal; Female; Gout; Gout Suppre | 2017 |
Arthroscopic elimination of monosodium urate deposition of the first metatarsophalangeal joint reduces the recurrence of gout.
Topics: Adult; Arthritis, Gouty; Arthroscopy; Bone Transplantation; Debridement; Follow-Up Studies; Gout Sup | 2009 |
Long-term safety of pegloticase in chronic gout refractory to conventional treatment.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Drug Resistance; Enzymes, Immobilized; Female; Gout | 2013 |
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout.
Topics: Acute Disease; Adult; Aged; Alkaline Phosphatase; Allopurinol; Arthritis, Gouty; Chronic Disease; Cr | 2003 |
Effects of Rebixiao granules on blood uric acid in patients with repeatedly attacking acute gouty arthritis.
Topics: Acute Disease; Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Dicl | 2005 |
Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
Topics: Adult; Bicarbonates; Calcium Oxalate; Calcium Phosphates; Cross-Over Studies; Double-Blind Method; F | 2007 |
Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment.
Topics: Adolescent; Adult; Aged; Disability Evaluation; Female; Humans; Immunoenzyme Techniques; Immunologic | 2008 |
Thiazide prophylaxis of urolithiasis. A double-blind study in general practice.
Topics: Adolescent; Adult; Aged; Calcium; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up S | 1984 |
Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis.
Topics: Adolescent; Adult; Aged; Calcium; Female; Humans; Hydrochlorothiazide; Magnesium; Male; Middle Aged; | 1984 |
Blood pressure in survivors of myocardial infarction. The Coronary Drug Project Research Group.
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Body Weight; Electrocardiography; Heart Rate; Hum | 1984 |
Medical management of nephrolithiasis.
Topics: Allopurinol; Ambulatory Care; Benzothiadiazines; Calcium; Calcium Oxalate; Calcium, Dietary; Cation | 1982 |
A prospective study of nonmedical prophylaxis after a first kidney stone.
Topics: Adolescent; Adult; Aged; Calcium; Calcium, Dietary; Female; Humans; Kidney Calculi; Male; Middle Age | 1999 |
Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Topics: Aged; Blood Platelets; Clinical Trials as Topic; Death, Sudden; Depression, Chemical; Double-Blind M | 1978 |
[Antirelapse action of the flowers of the blue cornflower in urolithiasis].
Topics: Adult; Calcium; Clinical Trials as Topic; Diuresis; Drug Evaluation; Female; Humans; Male; Middle Ag | 1978 |
Allopurinol and thiazide effects on new urinary stone formed after discontinued therapy in patients with urinary stones.
Topics: Allopurinol; Calcium; Calcium Oxalate; Calcium Phosphates; Citrates; Drug Therapy, Combination; Huma | 1990 |
Randomized trial of allopurinol in the prevention of calcium oxalate calculi.
Topics: Allopurinol; Calcium Oxalate; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Kidney | 1986 |
223 other studies available for uric acid and Recrudescence
| Article | Year |
|---|---|
Metabolic evaluation of patients with recurrent, multiple or bilateral renal stones in Jaffna.
Topics: Calcium; Citric Acid; Humans; Kidney Calculi; Recurrence; Risk Factors; Uric Acid | 2020 |
Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation.
Topics: Atrial Fibrillation; Catheter Ablation; Humans; Recurrence; Risk Factors; Treatment Outcome; Uric Ac | 2022 |
Serum metabolomics identifies uric acid as a possible novel biomarker for predicting recurrence of chronic rhinosinusitis with nasal polyps.
Topics: Biomarkers; Chronic Disease; Humans; Nasal Polyps; Prospective Studies; Recurrence; Rhinitis; Sinusi | 2023 |
Routine Urinary Biochemistry Does Not Accurately Predict Stone Type Nor Recurrence in Kidney Stone Formers: A Multicentre, Multimodel, Externally Validated Machine-Learning Study.
Topics: Calcium; Calcium Oxalate; Humans; Kidney Calculi; Machine Learning; Recurrence; Risk Factors; Uric A | 2023 |
[A Case of Ammonium Acid Urate Staghorn Calculi Lost Only in the Drug Therapy].
Topics: Buffers; Humans; Kidney Calculi; Lithotripsy; Male; Middle Aged; Recurrence; Sodium Bicarbonate; Sta | 2019 |
[Inluence of osteoporosis and its causative factors on the prevention of recurrence of urinary stone disease].
Topics: Calcium; Humans; Osteoporosis; Recurrence; Uric Acid; Urinary Calculi | 2019 |
Predictive Factors for Kidney Stone Recurrence in Type 2 Diabetes Mellitus.
Topics: Aged; Asymptomatic Diseases; Body Mass Index; Calcium Oxalate; Causality; Cohort Studies; Comorbidit | 2020 |
Serum uric acid levels and the risk of recurrent venous thromboembolism.
Topics: Anticoagulants; Humans; Prospective Studies; Recurrence; Risk Factors; Uric Acid; Venous Thromboembo | 2021 |
Stress-stones-stress-recurrent stones: a self-propagating cycle? Difficulties in solving this dichotomy.
Topics: Adult; Aged; Case-Control Studies; Citrates; Creatinine; Female; Holistic Health; Humans; Life Style | 2017 |
Easy-to-use equations for the estimation of urine relative saturation in the assessment of risk of recurrence in urinary stones formers.
Topics: Algorithms; Ammonia; Calcium; Calcium Oxalate; Calcium Phosphates; Cysteine; Cystine; Hospitals, Urb | 2017 |
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Calcium; Calcium Oxalate; Calcium Phosphates; | 2017 |
Recurrence rates of urinary calculi according to stone composition and morphology.
Topics: Adenine; Adolescent; Adult; Age of Onset; Aged; Apatites; Calcium Oxalate; Child; Child, Preschool; | 2018 |
Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
Topics: Adult; Biomarkers; Calcium; Citrates; Cross-Sectional Studies; Female; Humans; Hypercalciuria; Hyper | 2018 |
[Nephrotuberculosis and urolithiasis].
Topics: Antitubercular Agents; Cohort Studies; Comorbidity; Diagnosis, Differential; Humans; Oxalates; Progn | 2018 |
24-h urine metabolic profile: is it necessary in all kidney stone formers?
Topics: Adult; Aged; Body Mass Index; Calcium; Citric Acid; Comorbidity; Diabetes Mellitus; Female; Humans; | 2018 |
Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
Topics: Adult; Calcium Oxalate; Calcium Phosphates; Citric Acid; Female; Follow-Up Studies; Humans; Hypercal | 2018 |
Long-term Recurrence Rates in Uric Acid Stone Formers With or Without Medical Management.
Topics: Aged; Female; Humans; Kidney Calculi; Male; Medication Adherence; Middle Aged; Recurrence; Retrospec | 2019 |
[Role of drinking and dietary factors in effective dissolution therapy and recurrence prevention of uric acid kidney stones].
Topics: Citric Acid; Drinking; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Mineral Waters; Recurrenc | 2019 |
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Topics: Adult; Aged; Body Mass Index; Citrates; Citric Acid; Cross-Sectional Studies; Female; Humans; Hyperc | 2013 |
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Asian People; Base Sequence; Child; Child, Preschool; | 2014 |
Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Topics: Aged; Biomarkers; Diabetic Nephropathies; Female; Humans; Hyperuricemia; Intraoperative Complication | 2014 |
Influence of clinical therapy and nutritional counseling on the recurrence of urolithiasis.
Topics: Adult; Body Mass Index; Calcium; Combined Modality Therapy; Counseling; Diet; Feeding Behavior; Fema | 2014 |
Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation.
Topics: Atrial Fibrillation; Biomarkers; Cardiac Catheterization; Cryosurgery; Female; Humans; Male; Middle | 2014 |
The effect of resveratrol on the recurrent attacks of gouty arthritis.
Topics: Animals; Arthritis, Gouty; Disease Models, Animal; Female; Kidney; Male; Mice; Mice, Inbred C57BL; R | 2016 |
The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
Topics: Adult; Age Factors; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Calcium; Case-Cont | 2015 |
Metabolic disorders in Turkish children with urolithiasis.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalc | 2015 |
Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
Topics: Adult; Aged; Calcium Oxalate; Female; Humans; Kidney Calculi; Magnesium Compounds; Male; Middle Aged | 2015 |
Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research.
Topics: Adult; Allopurinol; Female; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Recur | 2015 |
Lithogenic activity as a factor to consider in the metabolic evaluation of patients with calcium lithiasis.
Topics: Adult; Calcium; Chlorides; Citrates; Creatinine; Fasting; Female; Humans; Hypercalciuria; Hyperoxalu | 2015 |
[Epidemiological study on urinary stones in the region of Fez and the risk of recurrence].
Topics: Adolescent; Adult; Aged; Apatites; Calcium Oxalate; Child; Child, Preschool; Cystine; Female; Hospit | 2016 |
Uric acid bladder stones in congenital cyanotic heart disease.
Topics: Cyanosis; Gas Chromatography-Mass Spectrometry; Humans; Hydronephrosis; Hyperuricemia; Magnetic Reso | 2016 |
Metabolic risk factors in pediatric stone formers: a report from an emerging economy.
Topics: Adolescent; Age Factors; Ammonia; Calcium; Child; Child, Preschool; Citrates; Diarrhea; Female; Huma | 2017 |
Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents, Non-Steroidal | 2017 |
The Modern Metabolic Stone Evaluation in Children.
Topics: Adolescent; Biomarkers; Calcium; Child; Child, Preschool; Disease Progression; Female; Follow-Up Stu | 2017 |
The burden of major adverse cardiac events in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Area Under Curve; Chi-Square Distribution; | 2017 |
Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders.
Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Humans; Middle Aged; Multiple Sclerosis; Neuromyelitis | 2017 |
Discontinuous drug combination therapy in autoimmune ocular disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Blood Pressure; Drug Resistance; Dr | 2009 |
[Qualitative and quantitative analysis of urolithiasis with the Rietveld method (x-ray diffraction)].
Topics: Calcium Oxalate; Calcium Phosphates; Crystallography, X-Ray; Durapatite; Humans; Magnesium Compounds | 2008 |
Local factors compared with systemic factors in the formation of bladder uric acid stones.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Diabetes Complications; Female; Humans; Hydrogen-Ion Con | 2009 |
Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?
Topics: Aged; Aging; Blood Chemical Analysis; Female; Gout; Gout Suppressants; Health Expenditures; Humans; | 2009 |
Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possibl
Topics: Adult; Body Mass Index; Calcium Oxalate; Calcium Phosphates; Cross-Sectional Studies; Crystallizatio | 2009 |
Rate and frequency of recurrence of uroliths after an initial ammonium urate, calcium oxalate, or struvite urolith in cats.
Topics: Animals; Calcium Oxalate; Case-Control Studies; Cat Diseases; Cats; Magnesium Compounds; Odds Ratio; | 2009 |
The effect of restrictive bariatric surgery on urinary stone risk factors.
Topics: Adult; Anastomosis, Roux-en-Y; Body Mass Index; Calcium; Citric Acid; Female; Gastrectomy; Gastric B | 2010 |
Metabolic abnormalities in patients with recurrent stone formation in a hot territory.
Topics: Adolescent; Adult; Aged; Calcium; Climate; Female; Humans; Kidney Calculi; Male; Middle Aged; Phosph | 2010 |
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Topics: AIDS Serodiagnosis; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, | 2010 |
Clinical significance of uric acid dihydrate in urinary stones.
Topics: Aged; Calcium; Crystallization; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Recur | 2011 |
The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity.
Topics: Aged; C-Reactive Protein; Cholesterol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery | 2010 |
Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.
Topics: Calcium; Citric Acid; Counseling; Female; Humans; Male; Middle Aged; Oxalates; Recurrence; Risk Fact | 2011 |
Higher urinary excretion of inorganic phosphate during early induction chemotherapy predicts a good prognosis in childhood acute leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Child; Child, Preschool; Fem | 2011 |
Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Female; Humans; Kaplan-Meier Estimate; | 2011 |
The most important metabolic risk factors in recurrent urinary stone formers.
Topics: Adult; Calcium; Calcium Oxalate; Calcium Phosphates; Chlorides; Citric Acid; Creatinine; Humans; Mal | 2011 |
Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Diuresis; Female; Humans; Hypercalciuria; H | 2012 |
Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Topics: Age Factors; Angioplasty, Balloon, Coronary; Diabetes Mellitus; Female; Follow-Up Studies; Heart Fai | 2012 |
Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO.
Topics: Adult; Female; Humans; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Male; Middl | 2012 |
Large urate cystolith associated with Proteus urinary tract infection.
Topics: Aged; Aged, 80 and over; Female; Humans; Proteus Infections; Proteus mirabilis; Radiographic Image I | 2012 |
Reddish-orange discoloration of urine due to uric acid crystalluria after recurrent seizures.
Topics: Color; Crystallization; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Humans; Hydrogen-Ion Concentr | 2012 |
[Attack of gout].
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Arthritis, Gouty; Diagnosis, Diffe | 2012 |
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Topics: Adult; Aged; Citric Acid; Female; Humans; Hypercalciuria; Hyperoxaluria; Linear Models; Male; Middle | 2012 |
Effects of dietary interventions on 24-hour urine parameters in patients with idiopathic recurrent calcium oxalate stones.
Topics: Adult; Calcium; Calcium Oxalate; Citric Acid; Diet; Female; Humans; Hypercalciuria; Hyperoxaluria; K | 2013 |
Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
Topics: Adult; Calcium; Calcium Oxalate; Child; Citric Acid; Female; Humans; Magnesium; Male; Oxalates; Recu | 2003 |
Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes.
Topics: Apatites; Calcium Oxalate; Calcium Phosphates; Humans; Magnesium Compounds; Phosphates; Recurrence; | 2003 |
Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke.
Topics: Acute Disease; Aged; Brain Ischemia; Cerebral Hemorrhage; Female; Follow-Up Studies; Humans; Ischemi | 2003 |
Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.
Topics: Case-Control Studies; Female; Genetic Predisposition to Disease; Glycosaminoglycans; Humans; Italy; | 2003 |
Urolithiasis in geriatric patients.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Calcium; Calcium Oxalate; Calcium Phos | 2003 |
Exercise-induced acute renal failure associated with renal hypouricaemia: results of a questionnaire-based survey in Japan.
Topics: Acute Kidney Injury; Adolescent; Adult; Creatinine; Exercise; Female; Humans; Japan; Male; Multivari | 2004 |
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Comorbidity; Female; Humans; Kidney Calculi; Ma | 2004 |
The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis.
Topics: Adolescent; Adult; Antioxidants; Catalase; Female; Glutathione Peroxidase; Humans; Male; Middle Aged | 2005 |
Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units.
Topics: Adult; Body Mass Index; Calcium Oxalate; Calcium Phosphates; Female; Humans; Image Processing, Compu | 2005 |
Risk factors determining active urinary stone formation in patients with urolithiasis.
Topics: Adult; Calcium; Citric Acid; Female; Humans; Hyperoxaluria; Male; Middle Aged; Recurrence; Retrospec | 2005 |
Ethnic background has minimal impact on the etiology of nephrolithiasis.
Topics: Adult; Aged; Calcium; Citric Acid; Cross-Sectional Studies; Ethnicity; Female; Gout; Humans; Hyperox | 2005 |
Percutaneous nephrolithotomy for complete staghorn calculi in preschool children.
Topics: Calcium; Calcium Oxalate; Child, Preschool; Citric Acid; Female; Humans; Infant; Kidney Calculi; Lit | 2005 |
Central/diffuse abdominal perception of urological pain in children.
Topics: Abdominal Pain; Adolescent; Age Factors; Calcium; Child; Child, Preschool; Female; Flank Pain; Human | 2006 |
Metabolic abnormalities associated with calyceal diverticular stones.
Topics: Adult; Calcium; Diverticulum; Female; Humans; Hyperoxaluria; Kidney Calculi; Male; Middle Aged; Recu | 2006 |
Case 5: treatment options for acute gout.
Topics: Acute Disease; Anti-Inflammatory Agents; Gout; Humans; Male; Middle Aged; Patient Compliance; Recurr | 2006 |
Recurring exercise-induced acute renal failure with usual daily work.
Topics: Acute Kidney Injury; Humans; Ischemia; Kidney; Male; Middle Aged; Pain; Physical Exertion; Recurrenc | 2007 |
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005.
Topics: Aged; Allopurinol; Drug Administration Schedule; Drug Monitoring; Epidemiologic Methods; Family Prac | 2008 |
Clinical features and risk factors of postsurgical gout.
Topics: Aged; Case-Control Studies; Colchicine; Female; Gout; Gout Suppressants; Humans; Lower Extremity; Ma | 2008 |
Management of recurrent gout: Professional guidelines differ.
Topics: Gout; Humans; Practice Guidelines as Topic; Recurrence; Uric Acid | 2008 |
Five years of experience with selective therapy in recurrent calcium nephrolithiasis.
Topics: Adult; Aged; Benzothiadiazines; Calcium; Calcium, Dietary; Cyclic AMP; Diuretics; Female; Fluid Ther | 1984 |
Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Humans | 1983 |
[Practical experiences with antegrade local chemolysis of struvite/apatite, uric acid and cystine calculi in the kidney].
Topics: Acetylcysteine; Apatites; Bicarbonates; Citrates; Combined Modality Therapy; Cystine; Female; Humans | 1984 |
Juvenile gouty arthritis. Two cases associated with mild renal insufficiency.
Topics: Adolescent; Arthritis; Female; Gout; Humans; Kidney Diseases; Male; Recurrence; Synovial Fluid; Uric | 1984 |
When should patients with symptomatic urinary stone disease be evaluated metabolically?
Topics: Adult; Calcium Oxalate; Colic; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Male; Recurrence | 1984 |
Stone composition and metabolic study in urinary calculous disease.
Topics: Adult; Aged; Calcium; Calcium Oxalate; Calcium Phosphates; Female; Humans; Magnesium; Magnesium Comp | 1984 |
Piperacillin: a comprehensive study of its renal effects and uricosuric property in man.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Creatinine; Drug Evaluation; Female; Humans; Kidney; Mi | 1984 |
[Prevention of calculus recurrence in impaired kidney function].
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Calcium Phosphates; Electrolytes; Humans; Kidney; Ki | 1984 |
Dissolution of uric acid-urate stones and prophylaxis of recurrency with Magurlit.
Topics: Citrates; Drug Combinations; Humans; Hydrogen-Ion Concentration; Pyridoxine; Recurrence; Uric Acid; | 1983 |
Crystalline composition of urinary stones in recurrent stone formers.
Topics: Calcium Carbonate; Calcium Oxalate; Calcium Phosphates; Crystallization; Crystallography; Cystine; H | 1983 |
Quantitative observations on the crystalline composition of urinary stones.
Topics: Calcium Oxalate; Calcium Phosphates; Crystallization; Crystallography; Cystine; Humans; Magnesium; M | 1983 |
[Results of the determination of enteral calcium absorption and calcium kinetics with 47Ca in patients with chronic recurring urolithiasis].
Topics: Adult; Calcium; Calcium Oxalate; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; M | 1983 |
The stone clinic effect in patients with idiopathic calcium urolithiasis.
Topics: Adolescent; Adult; Aged; Calcium; Calcium, Dietary; Dairy Products; Drinking; Female; Follow-Up Stud | 1983 |
Uric acid and calcium oxalate nephrolithiasis.
Topics: Adult; Benzothiadiazines; Calcium; Calcium Oxalate; Diuretics; Humans; Kidney Calculi; Male; Recurre | 1983 |
Methodological aspects of examination of 24 hour urinary excretions in outpatients with recurrent urolithiasis.
Topics: Adult; Calcium; Female; Humans; Magnesium; Male; Recurrence; Specimen Handling; Uric Acid; Urinary C | 1983 |
Diagnosis and management of renal calculous disease.
Topics: Calcium; Colic; Female; Fluid Therapy; Humans; Kidney Calculi; Kidney Diseases; Male; Recurrence; Ur | 1983 |
Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300.
Topics: Adolescent; Adult; Aged; Allopurinol; Calcium Oxalate; Female; Humans; Male; Middle Aged; Oxypurinol | 1983 |
Renal tubular acidosis in recurrent renal stone formers.
Topics: Acidosis, Renal Tubular; Bicarbonates; Calcium; Creatinine; Female; Humans; Hydrogen-Ion Concentrati | 1984 |
Pathophysiology and signification of hypercalciuria in calcium stone formers.
Topics: Blood Glucose; Body Weight; Calcium; Female; Glucose; Humans; Kidney Calculi; Oxalates; Prognosis; R | 1984 |
Recurrent urolithiasis: a general-practice study of risk factors and clinical consequences.
Topics: Adult; Calcium; Cystitis; Female; Humans; Male; Middle Aged; Pyelonephritis; Recurrence; Risk; Urete | 1984 |
Renal handling of uric acid in patients with recurrent calcium nephrolithiasis and hyperuricosuria.
Topics: Adult; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Recurrence; Uric Acid | 1984 |
Bacteriological and crystallographical analysis of urinary calculi: aid to patient management.
Topics: Adolescent; Adult; Aged; Bacteria; Calcium Oxalate; Female; Humans; Male; Middle Aged; Phosphates; R | 1984 |
Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
Topics: Adult; Calcium; Calcium Oxalate; Female; Humans; Kidney Calculi; Male; Middle Aged; Oxalates; Recurr | 1983 |
Practical aspects of the handling of samples and evaluation of laboratory data.
Topics: Adult; Aged; Calcium; Citrates; Creatinine; Crystallization; Female; Humans; Magnesium; Male; Method | 1980 |
Renal stone disease--experience from a population study of women in Gothenburg, Sweden.
Topics: Adult; Age Factors; Ambulatory Care; Calcium; Female; Hospitalization; Humans; Kidney Calculi; Middl | 1980 |
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study.
Topics: Allopurinol; Benzothiadiazines; Calcium; Diuretics; Female; Humans; Kidney Calculi; Male; Prospectiv | 1982 |
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients.
Topics: Adult; Allopurinol; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Recurrence; Trichlor | 1982 |
Should patients with single renal stone occurrence undergo diagnostic evaluation?
Topics: Adult; Calcium; Demography; Female; Humans; Kidney Calculi; Male; Middle Aged; Recurrence; Uric Acid | 1982 |
[Recurrent urolithiasis--analysis of its etiology and treatment].
Topics: Adult; Allopurinol; Calcium; Female; Humans; Magnesium; Male; Middle Aged; Oxalates; Phosphates; Rec | 1982 |
Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis.
Topics: Calcium Oxalate; Humans; Hyperparathyroidism; Kidney Calculi; Recurrence; Uric Acid | 1982 |
Urine composition in patients with urolithiasis during treatment with magnesium oxide.
Topics: Calcium; Calcium Oxalate; Creatinine; Humans; Magnesium; Magnesium Oxide; Oxalates; Recurrence; Uric | 1980 |
[Incidence of metabolic disorders in patients with recurrent urinary calculi].
Topics: Adult; Aged; Calcium Oxalate; Creatinine; Diabetes Complications; Electrolytes; Female; Humans; Hydr | 1981 |
[Purine metabolism and recurrent nephrolithiasis].
Topics: Humans; Kidney Calculi; Purines; Recurrence; Spectrophotometry, Infrared; Uric Acid | 1981 |
Metabolic effects of bendroflumethiazide in patients with recurrent calcium oxalate stone disease.
Topics: Adult; Bendroflumethiazide; Calcium; Calcium Oxalate; Citrates; Citric Acid; Female; Humans; Magnesi | 1981 |
[Guidelines for prevention of recurrent urolithiasis (author's transl)].
Topics: Acidosis, Renal Tubular; Calcium; Cystinuria; Humans; Hydrogen-Ion Concentration; Oxalates; Recurren | 1981 |
Fanconi's syndrome and distal renal tubular acidosis after glue sniffing.
Topics: Acidosis, Renal Tubular; Adult; Electrolytes; Fanconi Syndrome; Female; Humans; Hydrogen-Ion Concent | 1980 |
Urine composition in patients with renal stone disease during treatment with allopurinol.
Topics: Allopurinol; Calcium; Creatinine; Female; Humans; Kidney Calculi; Magnesium; Male; Oxalates; Recurre | 1980 |
[Therapy and prevention of recurrence of urinary calculi].
Topics: Cystine; Humans; Oxalates; Recurrence; Uric Acid; Urinary Calculi | 1980 |
Oral purine loading for evaluation of uric acid excretion in patients with urinary calculi.
Topics: Administration, Oral; Adult; Aged; Female; Guanosine; Humans; Male; Middle Aged; Prognosis; Recurren | 1980 |
[Statistical analysis on urolithiasis in the Department of Urology, Osaka University Hospital during the period from 1965 to 1978 (author's transl)].
Topics: Adolescent; Adult; Aged; Calcium Oxalate; Calcium Phosphates; Child; Child, Preschool; Female; Human | 1980 |
[Current status of prevention and therapy of urinary calculi and peroral chemo-litholysis with special attention to the relationship of increased excretion of uric acid in oxalate lithiasis].
Topics: Calcium Oxalate; Crystallization; Humans; Oxalates; Recurrence; Uric Acid; Urinary Calculi | 1980 |
The application of atomic force microscopy for the detection of microcrystals in synovial fluid from patients with recurrent synovitis.
Topics: Arthritis; Calcium Phosphates; Calcium Pyrophosphate; Crystallization; Durapatite; Humans; Microscop | 1995 |
[The significance of quantitative computerized tomography in the long-term prognosis of ischemic stroke].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Brain; Cerebral Infarction; Child; Com | 1994 |
A practical approach to nephrolithiasis.
Topics: Calcium; Cystinuria; Humans; Kidney Calculi; Magnesium Compounds; Phosphates; Recurrence; Struvite; | 1995 |
Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis.
Topics: Adult; Aged; Aged, 80 and over; Antacids; Biomarkers; Calcium; Citrates; Citric Acid; Female; Follow | 1994 |
L3 acute lymphoblastic leukemia. Comparison with small noncleaved cell lymphoma involving the bone marrow.
Topics: Adolescent; Adult; Aged; Bone Marrow; Burkitt Lymphoma; Child; Female; Humans; Immunoglobulin M; Imm | 1994 |
Recurrence of acute renal failure and renal hypouricaemia.
Topics: Acute Kidney Injury; Adolescent; Humans; Male; Recurrence; Uric Acid; Xanthine Oxidase | 1993 |
Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
Topics: Adult; Allopurinol; Drug Administration Schedule; Gout; Humans; Middle Aged; Recurrence; Retrospecti | 1993 |
[Evaluation of uric acid transport in nephrons of patients with calcium nephrolithiasis and hyperuricosuria].
Topics: Absorption; Adult; Benzbromarone; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Nephro | 1993 |
Case in point. Tophaceous gout.
Topics: Arthritis, Gouty; Female; Humans; Microscopy, Polarization; Middle Aged; Recurrence; Uric Acid | 1995 |
Struvite stones: long term follow up under metaphylaxis.
Topics: Analysis of Variance; Bacterial Infections; Calcium; Chemoprevention; Citrates; Citric Acid; Creatin | 1996 |
[Microalbuminuria as one of the early diagnostic signs of kidney involvement in patients with a purine metabolic disorder].
Topics: Adult; Albuminuria; Female; Gout; Hematuria; Humans; Kidney Diseases; Male; Purines; Recurrence; Tim | 1996 |
Recurrent exercise-induced acute renal failure in renal hypouricemia.
Topics: Acute Kidney Injury; Adolescent; Exercise; Humans; Kidney; Kidney Tubules, Proximal; Male; Recurrenc | 1996 |
[A case from practice. Thrombocytosis].
Topics: Aged; Anemia, Hypochromic; Cystitis; Humans; Kidney Calculi; Male; Recurrence; Thrombocythemia, Esse | 1997 |
Urolithiasis.
Topics: Calcium; Citric Acid; Humans; Hyperoxaluria; Recurrence; Uric Acid; Urinary Calculi | 1998 |
Recurrent hepatosplenomegaly and peripheral blood cytopenia, persistent Epstein-Barr virus infection and central nervous system manifestation in a patient with lymphadenopathy and low serum uric acid.
Topics: Central Nervous System Diseases; Child, Preschool; Hepatomegaly; Herpesviridae Infections; Herpesvir | 1998 |
Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis.
Topics: Calcium; Citric Acid; Diet, Protein-Restricted; Dinoprostone; Female; Humans; Hydroxyproline; Kidney | 1999 |
[Clinical and metabolic features of renal calculi in adults in regard to age of onset].
Topics: Adult; Age of Onset; Aged; Calcium; Calcium Oxalate; Calcium Phosphates; Citric Acid; Comorbidity; F | 1999 |
Gouty arthritis in a female patient with mixed connective tissue disease.
Topics: Adult; Arthritis, Gouty; Diagnosis, Differential; Fatal Outcome; Female; Humans; Mixed Connective Ti | 2000 |
Hyperuricosuria in children: clinical presentation and natural history.
Topics: Abdominal Pain; Calcium; Child; Female; Follow-Up Studies; Hematuria; Humans; Kidney; Kidney Calculi | 2001 |
Proportional reduction of urine supersaturation during nephrolithiasis treatment.
Topics: Calcium Oxalate; Calcium Phosphates; Humans; Recurrence; Uric Acid; Urinary Calculi | 2001 |
[Hyperuricemia and gout--diagnosis].
Topics: Adenine; Adult; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Female; Go | 2002 |
Child's urinary lithiasis revealing a complete deficit in adenine phosphoribosyl transferase.
Topics: Adenine Phosphoribosyltransferase; Blood Urea Nitrogen; Child, Preschool; Humans; Hydrogen-Ion Conce | 1976 |
[Drug therapy and metaphylaxis of urolithiasis].
Topics: Alkalies; Citrates; Diuresis; Fluid Therapy; Gout; Humans; Hydrogen-Ion Concentration; Recurrence; U | 1978 |
Effect of granulocytic chalone on acute myeloid leukaemia in man. A follow-up study.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Blood Platelets; Blood Sedimentation; Bone Marrow | 1977 |
Time to cut for the stone.
Topics: Calcium; Crystallization; Cyclic AMP; Female; Humans; Kidney Calculi; Male; Oxalates; Recurrence; Ur | 1978 |
Clinical concepts of renal calculous disease.
Topics: Adult; Age Factors; Blood Chemical Analysis; Calcium; Child; Citrates; Cystinuria; Diet Therapy; Fem | 1975 |
Renal excretion of uric acid and its relation to relapse and remission in acute myeloid leukaemia.
Topics: Adolescent; Adult; Aged; Allopurinol; Creatinine; Female; Homeostasis; Humans; Kidney; Kidney Tubule | 1977 |
Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
Topics: Adult; Calcinosis; Calcium; Calcium Oxalate; Calcium Phosphates; Citrates; Collagen; Female; Humans; | 1979 |
Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
Topics: Adult; Calcium; Calcium Oxalate; Calcium Phosphates; Citrates; Creatinine; Female; Humans; Kidney Ca | 1979 |
Familial renal hypouricaemia: two additional cases with uric acid lithiasis.
Topics: Adult; Calcium; Humans; Jews; Kidney Calculi; Kidney Diseases; Male; Pedigree; Probenecid; Pyrazinam | 1979 |
Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones.
Topics: Bendroflumethiazide; Calcium; Electrolytes; Humans; Kidney Calculi; Recurrence; Time Factors; Uric A | 1979 |
Should recurrent calcium oxalate stone formers become vegetarians?
Topics: Calcium; Calcium Oxalate; Diet, Vegetarian; Dietary Proteins; Female; Humans; Male; Oxalates; Recurr | 1979 |
[Prevention of urinary calculi and their recurrence and the health behavior of patients with urolithiasis].
Topics: Adolescent; Adult; Aged; Attitude to Health; Calcium; Child; Child, Preschool; Female; Humans; Male; | 1979 |
The natural history of calcium urolithiasis.
Topics: Adult; Age Factors; Calcium; Female; Humans; Male; Prospective Studies; Recurrence; Retrospective St | 1977 |
Nephrolithiasis in patients with gout.
Topics: Allopurinol; Gout; Humans; Kidney Calculi; Recurrence; Uric Acid | 1978 |
Prevention of recurrences in uric acid nephrolithiasis.
Topics: Adult; Allopurinol; Citrates; Humans; Kidney Calculi; Potassium; Purines; Recurrence; Sodium; Time F | 1978 |
Calcium-uric acid nephrolithiasis.
Topics: Adult; Aged; Allopurinol; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Recurrence; Ti | 1978 |
Recurrence of canine urolithiasis.
Topics: Age Factors; Animals; Carbonates; Cystine; Dog Diseases; Dogs; Female; Male; Oxalates; Phosphates; R | 1977 |
Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
Topics: Allopurinol; Calcium; Cystoscopy; Female; Hospitalization; Humans; Kidney Calculi; Male; Metabolic D | 1977 |
Testosterone-producing ovarian tumor associated with erythrocytosis, hyperuricemia, and recurrent deep vein thrombosis.
Topics: Diabetes Mellitus; Female; Humans; Middle Aged; Obesity; Ovarian Neoplasms; Polycythemia; Recurrence | 1977 |
[Mineral composition and structure of primary and recurring renal and ureteral calculi].
Topics: Humans; Kidney Calculi; Minerals; Oxalates; Phosphoric Acids; Recurrence; Ureteral Calculi; Uric Aci | 1976 |
Current therapy for acute leukemia in childhood.
Topics: Antineoplastic Agents; Bone Marrow Diseases; Child; Humans; Leukemia; Leukemia, Myeloid, Acute; Pati | 1976 |
Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
Topics: Adult; Calcium; Female; Humans; Magnesium; Male; Oxalates; Phosphorus; Recurrence; Uric Acid; Urinar | 1975 |
The Filipino and gout.
Topics: Adolescent; Adult; Age Factors; Aged; Allopurinol; Cross-Cultural Comparison; Diet; Ethnicity; Femal | 1975 |
[Recurrent Urolithiasis during Childhood (author's transl)].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cystine; Czechoslovakia; Female; Focal Infection; | 1975 |
[Urolithiasis during childhood (author's transl)].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cystine; Female; Focal Infection; Humans; Infant; | 1975 |
Stone screening and follow-up are necessary?
Topics: Acidosis, Renal Tubular; Adult; Aged; Calcium; Cystinuria; Female; Follow-Up Studies; Humans; Hyperp | 1975 |
[The experimental and clinical studies on the urinary calculi with the special reference to the metabolism of uric acid. Report II: relationship between urinary uric acid excretion and recurrent urinary oxalate containing calculus formation with special r
Topics: Adolescent; Adult; Aged; Allopurinol; Female; Humans; Male; Middle Aged; Oxalates; Recurrence; Uric | 1975 |
Management of uric acid stone.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Male; Mi | 1992 |
Tophaceous gout as a fungating mass.
Topics: Adult; Gout; Humans; Male; Mycoses; Recurrence; Uric Acid | 1992 |
Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.
Topics: Adult; Biomarkers; Calcium; Calcium Oxalate; Citrates; Humans; Kidney Calculi; Male; Middle Aged; Ox | 1992 |
Recurrent kidney stones: causes and diagnostic criteria in patients from Campania (southern Italy).
Topics: Acidosis, Renal Tubular; Adolescent; Adult; Aged; Calcium; Calcium, Dietary; Child; Cyclic AMP; Fema | 1991 |
Prophylaxis of uric acid stones with alternate day doses of alkaline potassium salts.
Topics: Adult; Aged; Bicarbonates; Citrates; Citric Acid; Colic; Follow-Up Studies; Humans; Hydrogen-Ion Con | 1991 |
Effect of meal on the physiological and physicochemical actions of potassium citrate.
Topics: Adult; Aged; Alkalies; Ammonia; Calcium; Calcium Oxalate; Citrates; Citric Acid; Eating; Female; Hum | 1991 |
Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.
Topics: Calcium; Female; Humans; Long-Term Care; Magnesium; Male; Oryza; Oxalates; Phosphorus; Recurrence; T | 1991 |
Paediatric urolithiasis in Greece.
Topics: Adolescent; Bacteriuria; Calcium; Child; Child, Preschool; Female; Greece; Humans; Infant; Male; Oxa | 1991 |
A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis.
Topics: Acute Disease; Arthritis, Gouty; Chronic Disease; Evaluation Studies as Topic; Family Practice; Gout | 1991 |
Metabolic disturbance as a cause of recurrent hematuria in children.
Topics: Adolescent; Calcium; Child; Child, Preschool; Female; Hematuria; Humans; Infant; Kidney Calculi; Mal | 1991 |
[The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria].
Topics: Administration, Oral; Adolescent; Adult; Aged; Autoanalysis; Calcium; Chronic Disease; Female; Gout; | 1990 |
[Clinical study on recurrence of urinary tract lithiasis of ESWL].
Topics: Adult; Calcium Oxalate; Female; Follow-Up Studies; Humans; Lithotripsy; Male; Middle Aged; Phosphate | 1990 |
Dietary intake and habits of Japanese renal stone patients.
Topics: Adult; Calcium, Dietary; Diet; Dietary Proteins; Feeding Behavior; Humans; Incidence; Japan; Kidney | 1990 |
Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia.
Topics: Acute Kidney Injury; Adolescent; Antigens, Surface; Blood Cell Count; Child; DNA, Neoplasm; Female; | 1990 |
Relationship of plasma and urine composition to recurrence of calcium urinary stones in patients on drug therapy.
Topics: Adult; Allopurinol; Calcium; Chlorothiazide; Creatinine; Drug Combinations; Electrolytes; Humans; Mi | 1990 |
Polyarticular gout.
Topics: Acute Disease; Arthritis, Gouty; Diagnostic Errors; Female; Humans; Male; Recurrence; Sex Factors; U | 1989 |
[The prevention of recurrence of calculus: results of a regional study].
Topics: Adult; Calcium; Combined Modality Therapy; Diet; Female; France; Humans; Kidney Calculi; Lithotripsy | 1989 |
Stone formation and urine composition in calcium stone formers without medical treatment.
Topics: Adult; Aged; Calcium; Citrates; Citric Acid; Female; Follow-Up Studies; Humans; Magnesium; Male; Mid | 1989 |
[Metaphylaxis of urolithiasis, methods and results].
Topics: Calcium; Follow-Up Studies; Humans; Recurrence; Uric Acid; Urinary Calculi | 1989 |
Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
Topics: Adult; Calcium; Citrates; Citric Acid; Glycosaminoglycans; Humans; Magnesium; Middle Aged; Recurrenc | 1989 |
Clinical and laboratory approaches for evaluation of nephrolithiasis.
Topics: Calcium; Cystine; Humans; Kidney Calculi; Oxalates; Recurrence; Uric Acid; Urinary Tract Infections | 1989 |
Use of the discriminant index in dynamic treatment to reduce recurrence of calcium oxalate kidney stones.
Topics: Adult; Aged; Allopurinol; Calcium; Calcium Oxalate; Chlorothiazide; Diphosphates; Female; Follow-Up | 1985 |
[Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].
Topics: Calcium; Diet, Sodium-Restricted; Female; Humans; Magnesium; Male; Natriuresis; Oxalates; Phosphates | 1988 |
[Recurrence of upper urinary tract calculi].
Topics: Adolescent; Adult; Aged; Calcium Oxalate; Female; Humans; Kidney Calculi; Male; Middle Aged; Recurre | 1988 |
Consensus development summaries. Prevention and treatment of kidney stones. National Institutes of Health.
Topics: Calcium Oxalate; Humans; Kidney; Kidney Calculi; Lithotripsy; Recurrence; Uric Acid | 1988 |
Impact of allopurinol treatment on the prevention of hyperuricosuric calcium oxalate lithiasis.
Topics: Allopurinol; Calcium Oxalate; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Retr | 1988 |
Acute acid load in recurrent oxalate stone formers.
Topics: Acid-Base Equilibrium; Ammonium Chloride; Calcium; Citrates; Citric Acid; Humans; Kidney Function Te | 1988 |
[Hypercalciuria as a possible cause of recurrent hematuria in childhood].
Topics: Calcium; Child; Hematuria; Humans; Hydrochlorothiazide; Male; Recurrence; Uric Acid | 1988 |
[Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
Topics: Calcium; Diet; Female; Food Service, Hospital; Food, Formulated; Humans; Magnesium; Male; Oxalates; | 1987 |
[Clinical studies on recurrence of urolithiasis. (2) Hypercalciuria and recurrence of urolithiasis].
Topics: Calcium; Calcium, Dietary; Female; Humans; Male; Recurrence; Uric Acid; Urinary Calculi | 1987 |
Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide.
Topics: Adult; Allopurinol; Benzothiadiazines; Calcium; Diuretics; Drug Therapy, Combination; Electrolytes; | 1987 |
Medical treatment of idiopathic calcium nephrolithiasis.
Topics: Allopurinol; Amiloride; Calcium; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperoxalur | 1987 |
[Questionable significance of the chemical analysis of a single 24-hour urine sample in recurrent calcium oxalate nephrolithiasis].
Topics: Adult; Calcium; Calcium Oxalate; Creatinine; Female; Humans; Kidney Calculi; Magnesium; Middle Aged; | 1986 |
[Clinical observation of urolithiasis in Mie University Hospital].
Topics: Adolescent; Adult; Calcium Oxalate; Calcium Phosphates; Child; Female; Humans; Magnesium; Magnesium | 1986 |
Multiple recurrences of acute tumor lysis syndrome in an indolent non-Hodgkin's lymphoma.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Female; Humans; | 1985 |
Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
Topics: Adult; Calcium Oxalate; Citrates; Citric Acid; Crystallization; Female; Humans; In Vitro Techniques; | 1986 |
Urinary tract stones. Medical management.
Topics: Calcium Oxalate; Calcium Phosphates; Cystine; Female; Humans; Magnesium; Magnesium Compounds; Male; | 1985 |
[Lipid peroxidation in the evaluation of healing of myocardial infarction].
Topics: Adult; Aged; Female; Humans; Lipid Peroxides; Male; Malondialdehyde; Middle Aged; Myocardial Infarct | 1985 |
Family history of renal stones in recurrent stone patients.
Topics: Acidosis, Renal Tubular; Adult; Aged; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Re | 1985 |
Allopurinol treatment of renal calcium stone disease.
Topics: Adolescent; Adult; Allopurinol; Calcium; Female; Humans; Kidney Calculi; Male; Middle Aged; Recurren | 1985 |
Investigation and treatment of renal calculi.
Topics: Calcium; Chronic Disease; Combined Modality Therapy; Female; Humans; Hyperparathyroidism; Kidney Cal | 1985 |
[When does allopurinol treatment fail in recurring calcium lithiasis?].
Topics: Allopurinol; Calcium; Follow-Up Studies; Humans; Recurrence; Uric Acid; Urinary Calculi | 1985 |
The severity of infection stones compared to other stones in the upper urinary tract.
Topics: Adolescent; Adult; Aged; Aging; Calcium; Cystine; Female; Humans; Kidney Calculi; Male; Middle Aged; | 1985 |
White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction.
Topics: Adult; Aged; Aspirin; Cholesterol; Coronary Disease; Dipyridamole; Diuretics; Female; Hematocrit; Hu | 1985 |
Management of chronic and recurrent gout.
Topics: Adrenocorticotropic Hormone; Allopurinol; Chronic Disease; Colchicine; Dexamethasone; Diet Therapy; | 1971 |
Recurrent radiographic dye-induced acute renal failure.
Topics: Acute Kidney Injury; Adult; Dehydration; Diabetes Complications; Diatrizoate; Hemodynamics; Humans; | 1974 |
Withdrawal of allopurinol in patients with gout.
Topics: Adult; Aged; Allopurinol; Female; Gout; Humans; Male; Middle Aged; Recurrence; Substance Withdrawal | 1974 |
Recognition of myocardial infarction after cardiac surgery and its relation to cardiopulmonary bypass.
Topics: Alanine Transaminase; Angiography; Arrhythmias, Cardiac; Aspartate Aminotransferases; Cardiac Cathet | 1974 |
Partial nephrectomy in renal calculus disease.
Topics: Adult; Aged; Dilatation; Escherichia coli Infections; Follow-Up Studies; Humans; Kidney; Kidney Calc | 1973 |
Urinary tract calculi in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Colon, Sigmoid; Crohn Disease; Cystinuria; Female; Fract | 1973 |
Comparison of indomethacin and phenylbutazone in acute gout.
Topics: Acute Disease; Adult; Aged; Blood Sedimentation; Edema; Female; Gout; Humans; Indomethacin; Leukocyt | 1973 |
Pregnancy bacteriuria: the significance of site of infection.
Topics: Anemia; Antibodies, Bacterial; Bacteriuria; Female; Fetal Death; Humans; Hypertension; Kidney Diseas | 1973 |
Nephrolithiasis.
Topics: Calcium; Crystallization; Cystinuria; Diet Therapy; Humans; Kidney Calculi; Oxalates; Recurrence; Ur | 1974 |
Management of patients with urinary calculi.
Topics: Adult; Bacteriuria; Blood Proteins; Calcium; Creatinine; Female; Humans; Male; Middle Aged; Nephrect | 1974 |
Withdrawal of allopurinol in patients with gout.
Topics: Allopurinol; Evaluation Studies as Topic; Follow-Up Studies; Gout; Humans; Male; Middle Aged; Recurr | 1974 |
Hyperuricemia and gout in an employee population.
Topics: Adult; Age Factors; Alcoholism; Coronary Disease; Diabetes Complications; Diuretics; Gout; Humans; H | 1971 |